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ABSTRACT

LYNDA F. BJNEWALD.

Biochemical Characterization of Human Thy 1.

(Unde.r the di rect ion of Dr. An-Chuan Wang.)
The present studies were undertaken in order to a) verifY the
presence of a human Thy 1 antigen, b) demonstrate its similarity to
murine Thy 1, and c)

biochemical~

characterize the molecule.

Previously, a 25,000 molecular weight molecule had been isolated
from a human T lymphoblastoid cell line,

~~olt

3, using isolation

procedures most frequently used for the isolation of rodent Thy 1.

The

human Thy 1 (p25) was demonstrated to be biochemically similar to
murine Thy 1.2 by molecular weight and ability to bind Lens Culinaris
lentil lectin.

Recently, we confirmed similarity between the murine

and the human molecule by peptide maps and amino acid compositions.

In

addition, a strong cross-reactivity using ananti-p25 antiserum was
established with human IgG subclasses.

The antiserum did not react

with human IgM or IgA, nor with primate immunoglobulins or a battery of
other antigens.

Through a variety of immunoabsorption experiments,

through the use of various digestions, and known amino acid sequences,
the shared areas of homology were tentatively determined to be in the
intact disulfide bonds of the first and third domains of human IgG and
the 9-112 disulfide bond of Thy 1.
A form of the p25 antigen noted and partially characterized was
the p40 antigen, the dimerized form of the p25.

The p25 and p40 are

essentially identical in several aspects, such as amino acid
compositions, peptide maps, carbohydrate compositions , reactivity to
anti-p25 serum, and in aggregation studies.

It

~s

determined that the

iii

detergent sodium dodecyl sulfate tends to convert the p25 molecule into
the p4 0 form through some ather chemical means than di sulf ide hond
interchange.

The

~thod

of isolation and reagents used unequivocally

determines observed molecular weight.
Another form detected is the p16 which also reacted with anti-p25
serum, was similar by amino acid composition, slightly different hy
peptide mapping and definitely contained less carbohydrate than the p25
antigen.

~he p16 is pJssibly a cryptic antigen, a breakdown fonn of

the p25 molecule.
A 40,000 M'"W" molecule was isolated from human thymus which binds
lentil lectin, reacts with antiserun made to the p25 antigen and
possesses an amino acid composition very similar to that of the p25
antigen.

Data suggests that the Thy 1 antigen from human thymocytes

tends to dimerize more readily than that found on

~~olt

3 cells and that

this a Ltigen is present in considerably smaller amounts on human
thymocytes as compared with Molt 3 cells.
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CHAPrER 1
THE THY 1 MOLECULE

2

INTRODUCTION
The Thy 1 molecule w.as originally described as an antigen on mouse
t~us

and brain cells by Reif and Allen in 1964 (1).

In the mouse

there exists two serologically identified alloantigen~, Thy 1.1 (AKR)
and Thy 1.2 (C3B) (1).

The antigen has proved to be a useful cell

surface marker for thymocytes and mature T lymphocytes in mice (2).
The number of antigenic sites per thymocyte was determined to be
greater than 400,000 for Thy 1.2 (3) and about 600,000 for Thy 1.1 (4).
The antigenic activity of brain cells is approximately equal to tqymocytes on a packed tissue basis (1).
Thy 1 was one of the first cell su rface differentiation antigens
to be identified on lymphocytes.

The expression of Thy 1 varies during

different stages of differentiation

~

in mice it is present on

thymocytes and peripheral T cells but not on bone marrow (2) or
haemopoietic cells (5).

Such is not the case in the rat.

The amount

of antigen on rat and mouse thymocytes and brain is similar as is the
brain developmental pattern, but most peripheral rat T cells lack the
antigen.

In rats Tqy 1 appears earlier in development than in mice.

It is present on the pluripotent haempoietic stem cell, early lymphoid,
(both T and B) and non-lymphoid (megakaryocytes, mast cells, and some
eosinophils) progeny (4,6-8).

Rat Thy 1 possesses the Thy 1.1

antigenic determinant but not the Thy 1.2 determinant (9).

Xenogeneic

(rabbit) antiserum has been raised which detects a rat specific
determinant and rat-mouse cross reacting determinants (10).

Antigenic

sites on the Thy I molecule can be divided into determinants specific
for the Tqy 1 of the immunizing species and determinants which cross-

3

react between species (11-13).

Thy 1 is present extracel1u1arly; in

association with collagen based connective tissue in bone blood vessels
in rat lymphoid organs

(14).

In rodents, fibroblasts (15), some

epidermal cells (16), breast cells (17), and muscle cells (18) also
display the Thy 1 antigen.

Identity of tissue distribution is usually taken as a strong
indication of

homolo~r,

but this is not the case for Thy 1.

T~

1 is

found in similar concentration in canine brain when compared to rodent
brain, but there are considerably smaller amounts of canine Thy 1 in
thymus, lymph node, spleen, and bone marrow.

Surprisingly, the antigen

was detected in fairly large amounts in canine kidney Which has not
been seen in the murine system (13).

Unlike the mouse, Thy 1 is not a

marker for T cells in the Syrian hamster but is also expressed on the
majority of resting, peripheral B cells (19).

In the chicken a 25,000

molecular weight molecule has been isolated from brain and is assumed
to be the Thy 1 molecule but cannot be detected on chicken thymus (20).

4

SEROLOGY AND LOCATION OF THE THY 1 MOLECULE IN THE HUMAN
Thy 1 is expressed in large quantities in the grey matter of the
cortex and basal ganglia of human brain and lower quantities in white
matter of cerebrum and peripheral nerves (21).

Little controversy, if

any, exis ts concerning Thy 1 in human brain, however, contradict ions
exist in the literature concerning the location of Thy 1 in human
thymus (22-24).

Originally Tqy 1 was not dete cted at all in human tbymocytes
(13,25), although easily detected on human brain in amounts similar to
murine Thy 1 using cross-react ing ant ibodies to rat Thy 1.
detected on various organs and tissues at that time.

None was

McKenzie and

Fah re (26) detected human Thy 1 only in discrete area s of the thymus,
spleen, and lymph nodes but not on peripheral blood lymphocytes using
an antiserum prepared against a human brain Tby 1 antigen.

Cross-

reacting determinants were discovered on hunan fibroblasts and hunan
brain by t h e use of a rabbit anti-rat Thy 1 and by monoclonal antibodies to human brain Thy 1 which also reacted with human fibroblasts
(27 ) •

In contrast, Balch and Ades (28) using an antiserum prepared
against a 25 ,000 rlolecu1ar weight antigen isolated froI"Q f10lt 3 cells,
noted that t h e p25 antigen was prefere ntially expressed on peripheral T
lymphocyte s and not on brain tissue.

They also used an antiserum which

recognized a 25,000 MW membrane antigen, that was prepared against
monkey

tl~r mocytes,

to localize the antigen on normal human T lympho-

cytes and human T lymphoblastoid cells

(29).
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Sagi and Tanigaki (30) isolated and prepared a rabbit antiserum to
a glycoprotein from a cultured leukemic T cell, Molt
reacted with a
SKW-3.

T~

4. This antiserum

I-like glycoprotein isolated from a T leukemic cell,

Reactivity to their antiserum was widely distributed in all

human organs and tissues but predominated in brain and testis.
spleen, and peripheral blood

leuko~te

Thymus,

preparations were positive, with

heart, kidney, liver, and skeletal muscle displaying less antigen.
Ritter et ale (31) found human Thy 1 present in 0.1-0.5% bone
marrow cels and 0.2-10%

t~us.

They found that Thy 1 is confined to

early stages of T and B lymphocyte development but absent from all
myeloid cells.

Using a rabbit antiserum to rat brain Thy 1 and mono-

clonal antibodies to human brain Thy 1 they also found that all Thy 1
positive T cells are situated in the outer thymic cortex.
At this time one can only assume that the controversy arising
concerning the distribution of Thy 1 in the human is due to the
methods and materials used for the production of antisera and due to
the sensitivity of the techniques employed .

For example, Ritter et ale

(31) noted that the FACS (Fluorescein Activated Cell Sorter) gave
consistently higher values than did fluorescent microscopy.

6

MOLECULAR ST RUCTURE

There has been considerable disagreement as to the molecular
nature of the Thy 1 molecule.

Some investigators have found various

sizes for the nolecul e, such as 4 0,000 MW (32) or 60,000 HW (33) but
the recent general consensus has been a molecular weight of approximately 25,000 (34-36).

Some investigators have suggested it to be a

glycolipid (37 ,38), Ylhile others have suggested it is a glycoprotein

(39,40).

The present general consensus is that the molecule is indeed

a glycoprotein (33,41,42) while some question remains concerning the
presence or nature of a lipid moiety (36) or an association with lipid

The murine Thy 1 antigen isolated using deoxycholate as a
detergent has a molecular weight according to SDS-PAGE (sodiuM dodecyl
sulfate-polyacrylamide gel electropho resis) of 25,000 (43) as does rat
Thy 1 isolated from both brain and t1'\Ymocyt es (33,44).

Thy 1 from

canine brain and human brain using the same isolation procedure also
has a molecular weight of approximately 25,000 (45) as does Thy 1
isolated from human foreskin fibroblasts (26).

Thy 1 isolated from

human leukemic T cells also seems to have an apparent molecular weight
of 25,000 daltons (29,46).

However, the correct molecular weight has

been determined by sedimentation equilibriUM studies (35) and for rat
brain Thy 1 it is 17 ,500 and for rat thymocyt e Thy 1 it is 18

;roo.

Part of the molecule is carbohydrate, therefore the charge/mass ratio
gives an anomalous weight of 25,000 by SDS-PAGE.

The molecular weight

of the polypeptide portion of the molecule is 12,500.

The Stokes

radius of canine (3.0 nm) and human (3.25 nm) brain Thy 1 is similar to
that for the rat Thy 1 (45).
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The amino acid compositions of the various species of Thy 1 show
varying degrees of similarity.

The Thy 1 molecule is fairly

hydrophilic in its amino acid composition.

Published amino acid

compositions for various Thy 1 preparations from various tissues and
species are listed in Table 1.

Rat brain Thy 1 was sequenced in 1981 (36) and murine brain Thy 1
in 1982 (47).

These sequences can be seen in Table 2.

homology with immunoglobulin was found (48).

The rat Thy 1 consists of

I I I amino acids with two disulfide bonds from Cys

19 to Cys

8S.

Sequence

9 to Cys I I I and Cys

It has three N-linked carbohydrate structures at

residues Asn 23, 74, and 98.

The murine Thy 1.1 possesses an Arg at

position 89 while in Thy 1.2 there is a G1n.

The murine Thy 1 has 112

residues and is very similar to the rat Thy 1 except for two areas, one
at sequence 26-29 where there are four differences and a deletion and
one at residues 63-67 where there are five different amino acids.
The carbohydrate component has been found to be 20-30% of the Thy
1 molecule.

One group of investigators found marked differences

between rat brain and rat tnYmocyte Thy 1 carbohydrate compositions
(34).

Galactosamine was found in brain Thy 1 but not in thymocyte Thy

1 in contrast to sialic acid which was found in much greater amounts in
thymocyte Thy 1.

Given that differences in

co~position

are likely to

reflect much larger differences in structure, these investigators
suggest that the carbohydrate chains of brain and
be completely unrelated.

t~mocyte

Thy 1 may

All Thy 1 isolated from a homogeneous lympho-

blastoid cell line was demonstrated to bind to lentil lectin (43).

A

comparison of Thy 1 from lymphoma and from normal thymocytes showed a

heterogeneity of Thy 1 froM normal cells, but not on lymphoma cells

Published carbohydrate composi-:ions are shown in Table 3.
be seen considerable variability exists.

As can

This could be due to

carbohydrate complexi ty of Thy 1 molecule and also due to the n ature of
the carbohydrate assay accuracy which cannot be compared to the
accuracy attained by amino acid composition analyses.

Carbohydrate c ompl exity has also been demonstrated by le ctin
affinity studies and isoele ctric focus i ng

(50).

Only

50%

of rat

t hymocyte Thy 1 bO~.l!1d to lentil lectin ( 3 h ) a nd the S8J11e was s~own for
mouse t hy mocyt e !hy 1

(50)

while all brain Thy 1 binds to this lectin.

In addition, 25'0 of mouse thymocyte Thy 1 was shown to bin:! wheat germ
agglu t inin while 1 0 0% va s bou nd by co n c a nav a l in A.

Analys is by iso-

electric focusing revealed six charge variants, which after isolation
and treatment wit:-l neu raJ1'linidase showed that heteroge n eity was du e to
varJing amounts of sialic acid (SO).

Another group of inve s tigators

found that Thy 1 isolated from iITlP.lature roc:>use thymocytes possessed

~ess

sialic acid than that isolated from peripheral or mature T lymphocytes

(51).

Therefore on e can assune a considerable degree of heterogeneity

of the carbohydrate portion of the varjous Thy 1 molecu les.

Next to the q-llestion of function, the second most often posed
question is -- ::()w is the Thy 1 molecule anchored in the cell membrane?
Is there lipid a s s oc iation or is lipid covalently linked to the
molecule?

rl' here is no 11Y drophobic stretch of amino acids in t h e
r

se quence of th e molecule to form a tail piece or section to extend into

9

or through the lipid bila.yer of the cell membrane .
thymocyte Thy 1 can be

labell~d

in membranes by a photo-activated

reagent which partitions into lipid

Miller and Esselman

(38)

Yet , mouse

(52) .

have suggested that mouse Thy 1 is a

ganglios ide using experiments showing that Thy 1 cytotoxici ty could be
inhibited by various ganglios ides .
glycolipid (53) .

In contrast , other i nvestigators have not found Thy 1

antigenic activity in lipid material
that Tny 1 is

no~

They also snggested it could be a

(54,55) .

It has since been shown

a ganglioside, but a glycoprotein .

The molecule can

only be isolated in the presence of detergent , usually deoxycholate .
Membrane proteins

normCt~ly

associated wi th lipid bind large amounts of

non- ionic or weakly ionic jetergents, whereas other proteins do not

(56) .

The Thy 1 glycoprotein forms a micelle and does not bind to the

detergent itself (35) .

In the absence of DOC, the rat Thy 1 forms a

large homogeneous complex of approximately 300,000 MW .

The complex can

only partial ly be disso c iated by 4!~ guanidir:.um ch:oride s uggest ing that
the protein portion is not directly involved in the aggregation (35).

Barclay et al e ( 3 4 ) mentions a peak running in identical manner to
stearic acid during carbohydrate analysis of rat brain Thy 1 .

'"While

sequencing rat brain Thy 1, (',ampbe~l et ale (36 ) could isolatp t r ~
terminal peptide either in highly aggregated form or after purification
in Brig

96 .

The peptide appeared to have hydrophobic properties, yet

did not contain arw extended sequence of qydrophobic amino acids .

The

C-terminal peptide possessed ninhydrin-positive rmterial, gluc.os8....'TIine,
and galactosamine.

They suggest linkage to lipid and site precedents

in the Ii terature such as linkage through sulhydryl and amino groups of

10

the N-terminal cysteine of Escherichia coli murine-lipoprotein

(57) and

sulhydryl of the C-terminal cysteine of rhodotorucine A of Rhodosporidiun toruloides (58).

But with Thy 1 ltpid could not be at tached

through the sulhydryl of Cys III because it is bonded to Cys 9.

They

suggest that the carboxyl of Cys III could be the attachment site for
this material.
determined.

The nature of this hydrophobic moiety remains to be
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MOLECULAR BIOLOGY
The gene for Thy 1 is located on chromosome 9 in the mouse (59).
The rat Thy 1 gene has been cloned and sequenced (60) and the cDNA
sequence suggests a new and different regulatory mechanism for expression of the molecule.

The DNA sequence ends early at a position

corresponding to amino acid 103, 8 amino acids earlier than predicted
from the protein sequence.

There is no termination codon, and a pre-

sumptive polyadenylation signal which is part of the coding sequence i s
found 12 nucleotides upstream from the poly(A) tail.

One explanation

for this observation is that a deletion of the C-terminal coding
sequence was retained, however this phenomena has never been described
before.

The author's explanation is that the sequence at nucleic acid

positions 293-298 served as a polyadenylation signal in vivo and position 310 which is 12 nuc1eotides downstream served as the polyadenylation site.

Differential poly(A) site selection may control the

expression of the C-terminal coding segment.

Levels of Thy-1 expression change dramatically during cell
differentiation.

Crude thymus extract has been shown to cause mouse

Thy negative bone ma r row and spleen cells to become Thy 1 positive

(61).

Moriuchi et ale (60) suggest that thymic honnones may induce the

genetic me chanism necessary for the expression of Thy 1.

Th~r

also

found nucleotide sequence homology between Thy 1 cDNA and the mouse
light chain variable region to be 3610.

They propose that the Thy 1

gene may have inherited a remnant of a mechanism involved in gene
expression, namely differential polyadenylation such as seen with
membrane and secreted IgM.
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FUNCTION OF THE THY 1 MOLECULE
The Thy 1 molecule is a prime

exa~ple

ized molecule in search of a function.

of a fairly well-character-

Its function mlst be fairly

consistent in brain since a variety of species possess large amounts of
brain Thy 1 (13).

Although originally used as a T cell marker in mice

the antigen is not equally distributed in thymus or T cells across
species, therefore function ma.y be different from that in brain.

Thy 1 cannot be detected in the brain of newborn mice until seven
days postnatally (62).
(42).

The antigen increases to adult levels by day 23

During this time When the bulk of neural development occurs, an

increase in number of synaptic connect ions clos ely parallels the
increase in antigenic expression.
synaptosonal fractions (63).

The antigen appears enriched in

In brain reaggregate cultures, the

presence of Thy 1 closely correlates with the appearance of synapses

(64,65).

Therefore, in the brain Tqy 1 has been thought to be

exclusively associated with synapses (66).

Bu.t antibody to Thy 1

injected into rat hypothalmus selectively inhibits carbamyl choline
induced drinking (67).

This suggests that antibody reaction with Thy 1

results in blockade of cholinergic function.

~hese

experiments

indica ted that Thy 1 has no association with alpha-adrenergic funct ion.
Barclay et ale (34) sugges ts that funct ion ray be mediated by
carbohydrate structures since amino acid compositions between brain and
thymocyt e Thy 1 were ver:{ similar, "Whereas carbohydrate compos i tions
were not.
me~brane

The polypeptide chain may anchor

t~e

mole cul e in the

Rnd therefore provide a backbone for the display of different
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carbohydrate ligands.

These ligands may be recogn i tion si tes for

glycosyl transferases or lectins (68).

Hoessli et ale (5 1) also

sUGgests that carbohydr ate f1.mctions in cell-cell canmu.nic ations since
T lymphocyt e differentiation is accompanied by an in creas e in sialic
acid content of murine

~hy

Neu raminidase-treated periphera:

1.

lymphocytes do not houe to ly mphoid organs when injected intravenously
into syngeneic hosts but are quickly trapped by the li ver (69).

Thy 1

was also considered to have a role in cell-cell adhesion in studies of
J11.ap'ullarJ

tunor cells in cult ure (70) .

Specific interaction of anti-~hy

1 sera with Thy 1 antigen redirected the differe ilt iatio n p::ogram of
these cells.

Thy 1 may function in mediating selective adhesion of lymphocytes
to extracellular substrates during recirculation.
f ound to be associated with

collagen-b~sed

blood vessels in rat lymphoid organs (14).

~he

antigen was

connective tissue around
Thy 1 may not only be

i nvol vea in se2 e- ~ t i ve adh e s ion and nigra t io n of :lot just ly:rnJih ocyt es in
~h~f

circulation, but a l so of other

1 negative cell types .

Ritter

e~

ale (14) suggested a reciprocal relationshi p between ~~hy 1 on cells and
on connective tissue.
the Thy· 1 pes i":-ive
lym}.lhocytes (7 ) .

For example, in the rat lymph node and spleen,

conne~tive

tissue is surrounded by Thy 1 negative

In the P1Ouse, the vascular basei'1ent me mb ranes are Thy

1 negative, while recirculating

~

ce lls are

posi~ive.

Springer ~_t ale (71) consider's Thy 1 a "j u!'1ping " differe ntiation
antigen in contrast to a "lineage" antigen which are expre s sed in an
ontogenetically or flL.Y1ctionally orderly fashion.

"Jump i ng" ant ige ns

will occur on di stantly related tissues while J1'K)re closely relateci

14

tissues will not have the antigen.

Therefore they have different

functional properties from lineage antigens.

Carbohydrate appears to

be a prominent structural component of jumping antigens.

Another

striking property of jumping ant igens, such as that of the Forrsman
antigen, is that the change of antigen expression correlates with
cellular migration to a different tissue.
change (72).

Adhesive properties also

,Jumping antigens might have similar functions in very

different tissues.

Thy 1 has a direct role not only in normal, but also in neoplastic
T cell growth control.

Support for this is shown by

experL~ents

using

anti-Thy 1 antibodies to block Con A induced T cell mitogenesis (73)
and blockage of T lymphoma cell proliferation (74).
on leukemic and cancerous cells.

Thy 1 can be found

Human melanocytes are derived from

neural crest cells on Which Thy 1 is expressed.

Normal melanocytes do

not express the antigen Whereas melanocytes in certain naevi and
melanoma do (75).

These investigators suggested a role for Thy 1 in

cell-c e ll recognition and also stated that detection of the antigen can
be a prognostic, biological marker for melanoma.
Thy 1 positive lymphocytes below the melanomas.

They also found many
Similar results were

reported for lymphocytes in inflammatory and malignant infiltrates in
the skin (76) and lymphocytes infiltrating breast carcinoma (77).

They

speculated that either the lymphocytes were beginning to express Thy 1
or had acquired such from surrounding medium.

t·1aino and coworkers (78) used a rabbit ant i-mouse brain, which
precipitated a 25,000 dalton glycoprotein from Thy 1 positive cells,
but not from Thy 1 negative cells, to activate or initiate T lymphocyte
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proliferation.

Antisera to Thy 1 allo-determinants were neither mito-

genic nor inhibitory to anti-Thy 1 induced responses.

Their studies

suggest a Thy 1 activating determinant, the necessity of an accessory
cell, and a mobile plasma membrane necessary for interactions of Fc
receptors, H-2, la, and T200 glycoproteins.

Sequence homology was found between rodent neuronal Thy I and
immunoglobulin (47).

A lack of alpha-helix and possession of similar

circular dichroism also suggests that Thy 1 structure resembles an Ig
domain.

When compaied to IgD by circular dichroism both

show a negative peak at 217 nrl.
exists to be recognized (79).
bet~-rnicroglobulin

T~

1 and IgD

The authors suggest that the JOC)lecule
Homology with variable domains and

suggests that Thy 1 may be like the primordial

immunoglobulin domain and therefore places it in the immunoglobulin
superfamily.

This has led Jensenius and Williams

(79) to postulate

that the Thy I molecule is the T lymphocyte antigen receptor.

They

suggest that the role of the primordial Ig domain was to function as a
ligand for triggering cell-cell interactions by binding to a
recognizer, which was not

liQ~oglobulin-like

present day molecule with this function.

and that Thy I may be the

In support of this function,

a monoclonal antibody prepared against rat T cells recognizes a
cross-reactive determinant on Thy 1 and the Vk light chain of the
TEPCl5 myeloT!la protein (80).

These latter findings may imply a role

for the Thy 1 molecule in antigen and/or mitogen recognition or may
represent a cross-reaction or no

st~~ctur al

or functional significance.

In conclusion, theories concerning the function of Thy I include a
role in cell differentiation, in cell adhesion, in cell migration, T
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lymphocyte recognition, cell activation and therefore cell-cell
communication of some form, all of

~ich

remains to be proven.
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Table 1.

Amino Acid Comp ositions.

MOllse
brain a
Thy-1.2

Mouse b
Lymphoblastoid

Rat C
braln
Thy 1

Content (mol 10)

Rat C
thymocyte
Thy 1 Ir+

Rat C
thymocyte
Thy 1 r.r-

Human d
brain
rrhy 1

Dog d
brain
Thy 1

Humane
brain
Thy 1

Thy 1

Thy-1.1

0.8

n.m.

Asx

11.1

Thr
Ser
Glx
Pro
Gly

7.2
8.5

12.0
8.3
9.5
10.6
4.1
5.7

Cysa

Ala

Val
Met
Ile
Leu
Tyr

10.2

4.3

5.4
4.9
7.3

3.1
12.7
7.6
7.4
9.1
3.6
6.0
3.3
7.3

13.0

7 .1+
8.3

11.2

11.1

2.0

2.0
3.7
3.8
7. 2
7.5

2.0
3.8

4.0

4.0

3.7
6.6
5.8

4.1
6.9
7.5

from
from
from
from
from

12 .6
8.6
7.1
9.1
3.8

3.9

3.2

6.2

3 .l~

10.4

3.2

Arg

3. 2

2.9
7.4
0·9
4.1

6.7
8.9
3·5

G.o

3. 2

8.3
7·9
9. J
3. 0
5.0
3.2
7.4
0.8
4.0

7.8
1.5
3.9
9.4
3.5

1.8

Phe
His
Lys

aData
b Data
CData
dData
eData

4.6

Humane
foreskin
fibroblasts

1.1

4.9

11.4

8.fS
2.2

6.1
4.7
9.7
1.3
1·9
8.6
6.9
3.8

l~. 0

J-+.O

7.0
7. 2

7. 7
4. 8

2.7
7·5
12 .1

9·7
9.7
4.7
5·2
2.2

6.0
1.7
3.2
10.2
4.5
2.7
2.8
6.9
6.9

4.2

7·9
9.8
10.6
9·9
4.1

4.9
3·9
6.9
0·9
2.0

9.8
4.4
3.3
4.6
7.2
5.6

4.0
7.8
9·1
10.3
11·9
4.8
5.3
3.3
6.3
0·9
1·9
9·1

4.6
3.0
4.0
7.2
6.5

McClain et al (41).
Zwerner et al (42).
Barclay et al (34).
McKenzie et 8.1 (45).
Cotmore e t al (27) •

f\)
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Amino Acid Sequence of Rat and Monse Thy 1

Table 2.

10
Rat Thy 1

PCA -

Mouse Thy 1.1

ARG LYS

VAL -

ILE THR

SER -

LEU - THR -

ALA -

CYS -

LEU -

VAL -

ASN -

ASN -

LEU -

GLN -

HIS -

GLY - THR -

LEU -

30

20
AHG -

GLN -

LEU - K:3P - CYS - ARG -

HI~':;

- GLU - ASN - ASN - THR - A8N - LEU - PRO -

-

LYS -

ASP -

I\SN - 8m -

HIS -

VAL -

LEU -

ILE -

40
GLU -

PHE -

8ER -

LEU - THR -

ARG -

GLU -

LYS -

LYS ARG

LYS -

50

88H -

60

GLY - VAL - PRO - GLU - HIS - THR - TYR - ARG - SER - /\RG - VAIl - ASN - LEU - PHE - SER - ASP - ARG I

L~~

'rHR

SER -

I LE -

LYS -

VAL -

GLN -

rno -

GLU -

GLY -

ASP -

80

10
PHS -

ASN -

LEU - TH!1 -

LEU -

ALA -

ASN -

PHE -

rrHR -

Tlffi -

LYS -

ASP -

TYR -

90
ITYR - MEr -

CYS -

GLU -

PHE

100

LEU - ARG*- VAL - SER - GLY - GLN - ASN GLN
ALA

PRO -

THR -

8ER -

8ER -

ASN -

LY8 -

~1Er

110
rrHR -

SER

ILE -

ASN -

SER

VAL -

1L8 TYR

*For Mouse Thy 1.2 Position

89

ARG -

ASP -

LYS -

LEU -

VAL -

LYS -

CYS

is a GLN.

f\)

\.0

Table 3.

Carbohydrate Compositions.
Mouse brain a
Thy-l.2

Carbohydrate Residues/per Molecule

Mouse 1ymphoblastoidb
Thy-l.l

Rat brain c
Thy 1

Rat thymocyte c

Thy 11+
Fuc
Man
Gal
Glu
N-Ac-G1uNH2
N-Ac-GalNH2
NANA
Total
aData from

1.5

8.8
)~. 0
0.0
4.4
0.9
0. 1+

20.0
t~c Clain

Human d
brain

Canine d
brain

Thy 11-

1.8
8.7
6.3
0.0
8.6
0.0
3.5

1.8
11·9
1.8
0.6
6.3
1.0
0.2

1.0
10.6
5.5
1.3
7.0
0.0
1.8

0·9
9.4
6.9
1.1
8.3
0.0
2.2

3·9
13.2
5.6

4.0
14.2
4.3

8.0
1.8
1.3

10.7
1.2
2.7

23.9

29.0

32.0

35·0

36.0

38.0

et al (41).

b Data from Zwerner et a1 (42).
CData from Barclay et al (34).
dData from McKenzie et al (45).
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CHAPI'ER 2

MOLECULAR COMPARISON OF MJUSE THY-1 AND rrs HUMAN HOrv10Lcx}UE

(Molecular Immunology 19; 497-501, 1982)
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ABSTRAGr

Physicochemical techniques were used to verify previous immunechemical studies showing homology of the human Thy-l (formerly p25)
antigen and the murine Tqy-l or

antigen.

Peptide maps and amino acid

compositions showed close similarity between these two proteins;
however, they were not identical.

These data confirm that the p25

antigen is the human homologue of mouse Tqy-l.
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INTRODUCTION
Few human lymphocyte antigens have been characterized biochemically, other than determinations of their molecular weights.
Characterization of cell surface antigens and receptors has been
difficult due to the low density of membrane antigens and the large
nUMber of cells required for extraction of sufficient amounts of the
desired molecules.

Differentiation antigens from rats and mice, how-

ever, have been isolated in milligram quantities by extraction from
tissues or organs (1,2).

Using similar techniques, we previously

located a T cell antigen with a molecular weight (M.W.) of 25,000 from
a hlman lymphoblastoid T cell line (3).

We have now isolated a

sufficient quantity of this antigen to determine its peptide map and
amino acid (a.a.) composition, and we have compared some biochemical
properties of the human p25 and murine Thy-l antigens.

Our results

support the conclusion based on previous immunological comparisons that
the p25 antigen is the human homologue of murine

~hy-l.

MATERIALS AND METHODS

Analytical sodiun dodecyl sulfate - polyacrylamide gel electrop!1oresis (SDS-PAGE) was performed according to the method of Laemmli et
ale

(4) using 5-20% gradient gels on a Hoefer electrophoresis

apparatus.

The gels were stained wi th Coonas s ie blue.

r~olecular

weight (M.W.) was estimated by comparison with a M.W. marker kit
(Pharmacia, LMW).

Molt-3 cells from large scale cell cultures

(5) were

gr8wn in suspension with 15% h eat-i~activated fetal c~lf serum, and
isolation of the p25 antigen was perforned as described previously (3)
wit h the following m::>difications.
pE

The packed cells were suspended in a

7.4 lysing medillM of 0.01 M ~ris-HC1, 0.015

~

NaCl cont aining 0.01%

egg white trypsin inhihi tor (Sigma.), 0.01 M phenylmethylsulfonylflouride (CalBichem) and 0.0025% DNase (CalBiochem).

The fraction eluted

from a Sepharose 4B Lens culinaris coluTIn (Vector) was concentrated by
air dialysis.

An Ultrogel AcA-54 colunm was used, the desired

fractions were concentrated by air dialysis, and preparative SDS-PAGE
was performed.

Approximately 0.5 ml of concentrated eluent -was lay ered

on a gel 0.75 mm thick.

The sides of the gel were cut off and stained

with Coomassie blue to locate the 25,000 M.W.

b~nd,

Which was sliced

out, fJomoge n i zed, and extracted wi th 0.5% deoXj-r-chola te (DOC), 10 ru·1
Tris buffer.

The acrylamide was re80ved from the buffer by high-s peed

centrifugation (4000 xG) and the purified protein supernatant was
concentrated by air dialys is to 1.19 rn..g/ml.
p25 ant igen per ml of packed cells.

We isolated 0.14 mg of the

This isolated ant ige n was react ive

with antisera raised against another preparation of p2 5 antigen (3).
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This preparation of human p25 antigen (0.5 ml) and purified mouse
Thy-1.2 (5)

(0.45 mg at 1 mg/ml) were analyzed for a.a. composition by

standard procedures using a Durrum D-500 automatic amino acid analyzer.
Approximately 100 ug of protein was hydrolyzed in
at 110°C llilder vacuum for 18 hr.

6 N HC1,

O.l~ phenol

For the hu.r18.n p25 antigen additional

lyophilization and filtering were performed in order to remove discoloration and particles.

This discoloration was assumed to be due the

presence of DOC.

Sperm whale myoglobin (SWt1) was used as a control and subjected to
the same procedures as the Thy-l and p25 ant igens.
co~position

was calculated as follows.

The corrected a. a.

For each a.a. the known number

of a. a. was divided by the known number of res idues for

SW~~,

and the

resulting figure was divided by the percent composition of the a.a.
determined in SWM from our analysis.

This factor was used to correct

the content of each a.a. for the Thy-1 and p25 antigen by multiplying
the observed percent composition to give a corrected percent
composition as follows:
correct ion factor

=

(known no. of a.a. in SWM) /
known no. residues in S'",Tj-·1)
(observed "!o composition in SWr.1)

and
corrected

% composition =

(observed ~ composition) x (correction

factor) •

A minimum of three runs were used to cal c ulate the compositions of the
Thy-l and p25 ant igens.
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Tryptic digests were performed on each sample (100-200 ug) in 0.05
M NH4HC03 buffer, pH
ratio of 1:50.
cellulose

eEL

f.R,

for

4

hr at 47°C vith an enzyme:substrate

The digest was applied to a O.l-rom micro-crystalline
400-10 thin-layer plate (Brinkmann Instruments).

First,

ascending chromatography was performed using n-buty1 alcohol:glacial
acetic acid:pyridine:water (15:6:12:10) solvent.

Buffer for electro-

phoresis in the second dimension consisted of gla c ial acetic
acid:pyridine:acetone:water (2:1:8:40) at pH
applied at 300 V for 105 min.

4.4.

Co nstant current was

After drying, the plate was sprayed with

a cadmiuhl-ninhydrin solut ion prepared bJ~ adding a

110

ni nhy drin solnt ion

consisting of R~, acetone and 20% glacial ace~ic acid to a l~ solution
of cadmium acetate at a ratio of 20 :1.

An ethanol precipitation -was perforr1ed o n t!1e remaining 150 ug of
material.

Three volumes of 100% ethanol were added to each sample, the

sample was incubated at -20° C for

48

hr and centrifuged at 2,000 rpm

for 15 min, the supernatant was decanted, and the precipitate was
redissolved in watp r.

During the ethanol pre cip itation, the hurlan

glycoprotein tended to redissolve when brought to room temperature.
Therefore, centrifugation was done at 4°c and the supernatant was
iWQediately decanted.

An additional composition and peptide map were

obtained us ing this rna terial.
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RESULTS

By SDS-PAGE, human Thy-1 (p25) and mouse ~hy-1.2 migrated with the
same Rf value.

This SDS-PAGE analysis indicated a M.W. of 25,000 for

both antigens.

In Table 1, a.a. analyses are expressed as the mean

number of each residue per 100 residues, excluding tryptophan.

The

mouse Thy-1 composition was similar to those reported previously (2,5) .
The human p25 was similar to mouse and rat Thy-1 (1) except in the
amounts of glycine and alanine present.

The composition of SWM

compared favorably with its published composition and was used to
derive a correction factor, as described above.
in a correction difference of more than 10%.

This rarely resulted

Hydrolysis of the 0.5%

DOC-Tris eluting buffer showed no interference with a.a. resolution.

In order to test whether the high content of glycine and alanine
in the p25 antigen (Table 1) was real or an artifact, we performed an
ethanol precipitation in order to remove any contamination due to
eluting buffers.

~he

glycine and alanine contents remained constant.

The peptide

r~ps

obtained for p25 and Thy-1.2 were quite similar

although not identical (Fig. 1).
found.

~he

Several homologous peptides were

two spots that migrated farthest in the electrophoretic

direction were arginine and lysine as determined from maps of other
proteins containing arginines or lysines in juxtaposition, with no
intervening trypsin-sensitive amino acids.

DISCUSSION
Previous Drumunological data have suggested identity or close
similarity between the human p25 and JOOuse Thy-1 antigens (3).

They

have similar fv1.W., they are glycoproteins, and they share identical or
cross-reactive antigenic determinants.

Our comparison of the a.a.

compositions and peptide maps of the two molecules (Table 1 and Fig. 1)
indicates that they are closely related molecular species.

Differences

observed in the migration patterns of the p25 and murine Tby-1 antigen
in the chromatography dimension could possibly be due to differences in
carbohydrate moieties and not necessarily peptide differences.

At

present Ii ttle is known concerning the carbohydrate compos i tion of
human Thy-1 antigen, whereas a large amount of data is available
concerning the murine and rat Thy-l antigens (2,5).

For example, the

carbohydrate composition of murine Thy-l is about 2lf/o of its M.W. and
for the rat this figure is 3Cf/o (1).

Barclay et ale (1) found a M.W. of

25,000 for rat Tby-l by SDS-PAGE, but by sedimentation equilibrium the
~1.W.

of rat brain Thy-1 was 17 ,500 and that of rat thymocyte Tby-1

18,700.

Thus they calculated the polypeptide portion to be approxi-

mately 12,500 daltons.

We assume that the carbohydrate portion of the

human antigen is similar to the murine and rat antigens since
similarity was observed by peptide mapping.
could be appreciably lower than 25,000.

The M.W. of human Tby-l

Quantitation of the

carbohydrate moiety and its effect on the peptide mapping of these
antigens is underway.
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Subtle differences were observed not only in the migration
patterns of the peptide maps but also in a.a. composition.

These minor

differences could be due to (a) our isolation procedure, (b) the fact
that our antigen was derived from a
(c) differences in cell function.

~mphoblastoid

cell line, or

Our technique of isolating large

quantities of the p25 antigen by gel and lectin affinity chromatography
could yield an antigen different from that retrieved by immunoprecipitation with specific antisera.

For exaMple, Barclay et ale (1)

isolated a Tby-l antigen that bound to a lectin column and one that did
not; both reacted with anti-Thy-l serum.

They varied only slightly in

amino acid composition, with greater differences in carbohydrate
composition.

Comparisons between lectin-purified p25 and immunopre-

cipitated p25 are now in progress in our laboratory.

We assume that the antigen isolated from

t~e

lymphoblastoid cell

line Molt-3 is identical to that found on normal lymphocytes in spite
of an altered genome and expression of new antigens in these cells.
Support for this

ass~ption

tion experiments (3).

derives from our earlier immunoprecipita-

Also, in several cases identical molecules have

been isolated from normal tissue and from malignant cell lines,
including immunoglobulins, rosette receptors, and antigens such as
beta2-microglobulin (6), HLA alloantigens (7) and, recently, mouse
Thy-l.1

(8).

The functional role of the murine and hunan Thy-l antigens is
unclear at present.

Conservation of structure of Thy-l antigen between

species supports the theory of a necessary specific function.

In the
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mouse this antigen is found on
cells (1).
T~-l

t~ocytes,

mature T cells, and brain

In the rat, brain and bone marrow cells are positive for

whereas peripheral T lymphocytes are negative (1).

In humans,

the p25 antigen seems to be preferentially expressed on peripheral T
lymphocytes and not on brain tissue (9).

Ma ino et ale (10) have

suggested that the murine Thy-l antigen is involved in T cell activation and proliferation, and McClain et ale (2) have suggested that the
Thy-l antigens establish synaptic connections which are conserved in a
variety of species and tissues.

Perhaps the subtle differences between

Thy-l antigens reflect differences in function.

Correlations between

the structure and function of these antigens, as well as information
about their evolution, may be revealed by a.a. sequencing.

Such

studies are now in progress in our laboratory with murine and rat
and with the human p25 antigen.

T~-l
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Amino acid compositions of mammalian lymphocyte Thy-l antigens

Table 1.

Content (mol

Amino
acid

Mouse
Thy-1.2

Human
Thy-l
(10.0)d

12.4

(10.8)d

~)

in
Mouse
Thy-1.2 a

Mouse
Thy-l.1 b

Rat
Thy-l .1 c

13.3

12.0

12.6

ASX

11.5

THR

6.7

(6.2)

7.9

(7 .3 )

8.1

8.3

8.6

SER

6.2

(6.0 )

8.3

(8.0)

8.5

9.5

7.1

GLX

12.2

(11.7)

10.8

(10.2)

11.3

10.6

9.1

PRO

5.7

(5 .5 )

4.1

(3 .9 )

3.7

4.1

3.8

GLY

10.3

(9.9)

5.7

(5 .4 )

5.1

5 •7

4.9

ALA

10.0

(9.6 )

5.0

(4 .8)

3.9

4.6

4.8

VAL

7.1

(7 .9 )

6.2

(6.8 )

7.8

7.8

7.4

MEr

0.9

(0.8 )

2.0

(1.7)

1.3

1.5

0.9

ILE

4.4

(5 .3)

3.8

(4 .6)

3.8

3.9

4.1

LEU

9.2

(8 .6)

13.5

( 12.4 )

10.0

9.4

11.2

TYR

2.3

(2.1)

3.1

(2.8 )

3.4

3.5

2.0

PHE

3.7

(3.0)

2.7

(2.2)

3.0

3.2

3.7

HIS

1.4

(1.9 )

2.8

(3.8 )

3.6

3.7

3.8

LYS

4.3

(4.9 )

6.8

(7 •7)

7.6

6.6

7.2

Affi

2.7

(2.7)

4.8

(4.q)

6.3

5.8

7.5

aFrom Acton et al. (5).
- b From Zwerner et ale (8).
cFrom Barclay
dCorrected

~t ale

(1).

%composition

(see Materials and Methods).
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Fig. 1.

SDS-PAGE analysis of human Tny-1 (p25) antigen (a) and murine

Thy 1.2 (c).
comparison.

Low molecular weight markers (b,d) are shown for
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Fig. 2.
antigens.

Tryptic peptide maps of (A) murine Thy-l and (B) human p25
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ANTIGENIC DEI'ERMINANT (S) SHARED BY THE HUMAN THY 1 AND HUMAN IgG

(Accepted by Immunobiology, January 1984)
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A human T cell differentiation antigen (p25) previously described
as being the mouse theta equivalent has been examined for shared
antigenic determinants with tmmunoglobulin.

A strong cross-reactivity

of an antiserum prepared against p25 antigen was established with human
IgG subclasses.

This antiserum does not react with human IgM or 19A,

nor with primate immunoglobulins.

The shared determinants appear to be

associated with the disulphide-bonded cysteines in the first and third
constant domains of the 19G molecule and the 9-112 disulfide bond of
Thy 1.
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INTRODUCT ION

Thymus derived (T) lymphocytes are defined classically by their
expression of receptors for sheep red blood cells (1).
constituents of the T cell membrane include:
Fc receptor

Other

HLA antigens (2),

(4)8 2-microglobulin (3), and numerous antigenic structures

associated only with T cells (T cell specific cellular antigens) as
defined by either heterologous or monoclonal antibodies

(5).

The products of immune responses, specific antibodies, and antigen
specific T cell receptors are exquisite examples of recognition units
for foreign and self antigenic structure.

Whether the Thy-l antigen is

the primordial immunoglobulin domain and possibly the T cell receptor
as first proposed by Jensenius and Williams

(6) is still enigmatic,

although our data render support for this proposal.

In this study,

find that an antiserum made to a T cell specific product
Thy-l molecule
human IgG.

~

(7), the hunan

(8), can also react with a B cell specific product,

MATERIALS AND METHODS
Antiserum.

The antiserum was prepared as described previously (7).

Briefly, a 25,000 M.W. fraction of cell membrane was isolated from a
human T cell li ne and inj ect ed intramuscularly in complete Freund's
adjuvant into a rabbi t.

The second a.nd third inj ect ions we re gi yen 14

and 28 days later in incomplete Freund's adjuvant.

The antiserum

obtained was heat inactivated and used without any adsorptions.
Specificity of the antiserum for human T cells is as previously
described (7,8).
Cytotoxicity assay.

The specificity of the antiserum for different

lymphoblastoid cell lines was determined by using the 51Cr release
cytotoxicity assay as described previously

Cell lines.

(9).

The cell lines were graciously donated by Dr. Jean Michel

Goust and Dr. Jan Minowada.

ELISA assay.

~1icrotiter

plates (Linbro) with 8x12 wells were used.

The wells were coated with 100 ul of antigen (1-2 ug/ml).
were incubated at 37 ° C for 2 hr or at 4 ° C overnight •

The plates

Plates were

washed 3x with Dulbecco's phosphate-buffered saline (DPBS) and blocked
with 5% bovine serum albumin (BSA) , incubated at 37°C for 30 min or 1%
ESA overnight and washed 3x with DPBS containing 0.05% Tween-20.

To

each well, 100 ul of diluted antibody was added and the plate incubated
at 31°C for 2 hr.

The plates were then washed 3x with DPBS + Tween.

100 ul of a 1:2000 dilution in 1% BSA of goat anti-rabbit antisera
coupled with horse radish peroxidase was added to each well and
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incubated for 1 hr at 31·C.
with DPBS + Tween.

The plate was then washed extensively (6x)

Addition of 100 ul/we11 of 0.03% AHrS (2,2'-azino-

di-3-et~l-benzthiazolin-sulfonate, Boehringer, ~~nnheim,

in 0.1 M Na-citrate, pH 4.0, plus 0.003% H202 was made.

W. Germa~)
The plate was

covered and read between 15 and 30 min. in a Multiscan at 414 nm.

Source of Antigens.

Samples used included rat IgG (Miles Laboratory),

chicken, cow, and sheep immunoglobulin (Pentex, Inc.), conalbumin (Dr.
R.E. Feeney), alphal-antitrypsin (Dr. Philippe Arnaud), bet~- rri cro
globulin (Ira Rosenshein), and human albunin fraction V.

Pooled

immunoglobulins from human, gorilla, and rhesus monkey as well as human
myeloma IgG, IgA, and Wa:denstrom's IgM were isolated from sera by
precipitation with

sodi~~

sulphate, ion-exchange chromatography using a

DE-52 column, and gel filtration chromatography using a Sephadex G-200
or Sephacryl S-300 column as previously described (10).

These Dnrnuno-

globulins were reactive with antiserum made to hunan immunoglobulins.
Human transferrin was isolated by rivanol precipitation, starch-block
electrophoresis, and gel filtration chromatography using a Sephadex
G-100 column as previously described (11).

Cyanogen bromide (CnBr) coupling to Sepharose 4B.

Pooled normal human

IgG, G-200 fraction, 150 mg, was coupled to 10 g CnBr activated
Sepharose 4B according to the procedure of March et ale (12).

Absorption experiments.

The pooled hUMan IgG coupled Sepharose 4B ~s

washed once with 1 M acetic acid, centrifuged, and washed 3x with PBS.
Five hundred ul of antiserum was added, the sample was vortexed, and
allowed to stand at room temperature for 2 hr.

The sample

~s

again
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vortexed, centrifuged, and the absorbed antiserum was removed.
absorbed antiserum was used in the ELISA
human IgG and the p25 antigen.

ass~r

This

to test reactivity to

The IgG coupled Sepharose 4B column was

then washed once with PBS and then 2x with 1 M acetic acid.

The acetic

acid wash was lyophilized and reconstituted to 500 ul with PBS and
tested for its reactivity to hunan IgG.

Molt

4 cells (lxlcP) were washed 2x with PBS.

Five hundred ul of

antiserum was added to the cells and incubated on a shaker for 2 hr at
37°C.

The cells were centrifuged and the absorbed antiserum removed

and tested in the ELISA assay against human IgG and the p25 antigen.
Care was taken to maintain an equivalent volume of antiserum (500 ul)
for absorption with the Sepharose 4B coupled with human IgG column, the
Molt 4 cells, and in the 1 M acetic acid wash.

Reduction and Alkylation.

IgM, IgA, and IgG protein samples were

reduced and alkylated and the heavy (H) and light (L) chains separated
as described previously (13).

Isolation of IgG Fab and Fc fragments.

Papain digestion of human IgG

myeloma proteins and isolation and purification of Fab and Fc fragments
was performed as described previously (14).

Digestion of Fab fragments.

Tryptic digests were perfonned on each

sample in 0.05 ~1 NH4HC03 buffer, pH 7.8, for 4 hr at 37°C with an
enzyme:substrate ratio of 1:50.

Staph v-8 protease digestion was

performed as desc ribed in Methods of Enzy1OO1ogy (15).

Briefly, protein

samples were dissolved in distilled H20 pH 4.0 at a 10 mg/ml solution
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and allowed to equilibrate for

5 min at 37°C.

The enzyme was dissolved

in 1 M Na acetate pH 4.0 and added to the protein at a ratio of 1:100
and incubated at

37°C for 20 min.

The reaction was stopped by the

addition of l~ trichloroacetic acid.
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RESULTS
Cytotoxicity assays were performed on a number of human and murine
T cell lines in order to establish T cell specificity of the antiserum
and relative amount of antigen per cell.

Results are shown in Table 1.

As can be seen from this Table, not all T cells are react ive wi th this
antiserum according to the cytotoxicity assay, however, the antiserum
possesses a high reactivi ty for Bal blc thymocytes.
Determination of specificity of the antiserum was accomplished
through use of the ELISA assay.

React ivi ty to human IgG was determined

to be as great as for the human purified p25 antigen (Figs. 1 and 2).
The antiserum reacted with three different subclasses of IgG, i.e.
IgGl' IgG 2 , and IgG3 (Fig. 2).

There was little or no reactivity to

human albumin, conalbumin, alphal-antitrypsin, transferrin; sheep,
chicken, or cow immunoglobulins; to rhesus, baboon, or gorilla
immunoglobulin; rat myeloma, human IgM, human IgA, k or A light chains,
reduced and alkylated human IgM heavy chain, IgA heavy chain, or IgG
heavy chain.

Mild react ivi ty (appro ximately 35"/0) was seen wi th rouse

IgG and rat IgG, but none with mouse IgG2b and IgM (Fig. 3).

Both the

Fab and Fc fragments from papain digested human IgG reacted with the
antiserum (Fig. 4).
In order to determine Whether the

antise~~

was recognizing a

determinant shared by both the human Thy-l antigen and human IgG,
absorption wi th human IgG coupled to Sepharose 4B or wi th Molt 4 T
cells was performed.

As can be seen in Fig. 5, the major i ty of the

reactivity of the antiserum to IgG was removed by absorption wi th IgG
while reactivity to IgG was also removed by absorption with Molt 4
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cells (Fig. 5c).

Partial reactivity to the 19G (Fig. 5d) was recovered

from the 1 M acetic acid wash from the 19G coupled Sepharose 4B column.
In Figure 6, reactivity to the p25 antigen was removed by absorption
with Molt 4 cells and the 19G coupled to Sepharose 4B yet recovered
from the 1 M acetic acid wash.

Previous studies

(7) using immunoab-

sorption and immunodepletion have shown complete removal of reactivity
to the p25 antigen.

Furthermore, as can be seen in Fig. 7, reactivity

to 19G Fab fragments was removed (1:80) or greatly diminished by
trypsin digestion while only moderately diminished by Staph-V8 protease
digestion.

55

DISCUSSION

Thy 1 is a well-characterized membrane antigen wi th a wide tissue
distribution (16).

Although it is mainly present in high levels in

neuronal cells and T cells, recent studies indicate that it is also
detected in immature B cells (17).

Recently, new ideas have appeared

in the scientific Ii terature purporting a new function for the Thy 1
antigen.

Williams & Gagnon (18) have discovered structural and

sequence homology between murine

Th~y

1 and immunoglobulin, especially

with the V (variable) region sequence.

They suggest that Thy 1 may be

like or is the primordial immunoglobulin domain.

Jensenius & Williams

(6) go so far as to suggest that Tqy 1 may replace current concepts of
the T cell receptor.

According to these investigators, the Thy 1

molecule is the primordial immunoglobulin domain Which functions as a
ligand which triggers cell-cell interactions by binding to a recognizer
and that these two molecules, the ligand and the recognizer, could have
evolved to produce the antibody and the histocompatibili ty systems.

In earlier works, we have shown that the p25 antigen isolated from
the human leukemic line, r-101t 3 is the human homologue to murine Thy 1

(8).

Similar procedures for isolation of both the human and mJrine

Thy-l antigens were used; they both have identical molecular

we~hts,

both bind Lens culinaris lectin and are cross-reactive as shown by
immunodepletion and absorption experiments (7).

In addi tion, the p25

antigen and muse Thy 1.2 have similar though not identical tryptic
peptide maps and similar amino acid compositions (8).
set out to determine whether the
with human immunoglobulin.

hup~n T~-l

Therefore, we

molecule shares homology

As can be seen in Figures 2 and 5, the anti-p25 antiserun
recognizes a common determinant on the p25 antigen as well as on human

IgG.

Since both the Fab and Fc fragments reacted with the antiserum

(Fig. 4), we began to look for simila r sequences in the IgG heavy chain
and murine

~hy

1 yet, could not be found in human IgM or IgA.

The

Sequence of Proteins of Immunological Interest Atlas (20) yielded two
such positions.

One was 123-126 and 238-2Lt2 of IgG, but there was not

such a sequence in Murine Thy-l (18,19), while the other position was
Ih4-1t~7

and 367-310.

However, the amino acids in the latter positions

are not exactly in the same sequence as murine Thy 1, thus prompting
examination of the disulfide bonds (first and third constand domain) of
hlunan IgG.

As can be seen in Fig. 8, the sequence C L V-C

conserved in most heavy chain domains.

V are

It is the identity of the

surrounding amino acids which determine distinctive antigenicity.
Reduced and alkylated IgG heavy chain is no longer reactive with the
antiserum and on this basis one might predict the sequence of the hunan
Thy 1 disulfide bond and the analogous Elurine disulfide bond 9-112, as
the IOsition which closely resembles or is identical to the disulfide
bonds of human IgG.

Thus, if the antiserum was recognizing the

disulfide bond in human IgG, trypsin should destroy this reactivity
since a lysine is located at positions 147 and 370.
that digestion wi th Staph

v-8

Also, we predicted

protease, which cleaves only at glutamyl

residues in the system used (15), would not affect react ivi ty.

These

expected results were found with two different IgG Fab fragments as
shown in Fig. 7.
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The antigen that was injected into the rabbit had been extracted
from cell membrane and therefore had antigenic determinants exposed
that normally would be buried in the cell membrane.

It could be a

determinant near the COOH terminal (one of many others), is being
recognized by this antisera.

A natural question to be raised, is could antigenicity due to
carbohydrate?

The Thy-l molecule has been shown to be 20-30"/0 carbohy-

drate (9,16,21,22), and have t~Iee N-linked carbohydrate chains (18).
However, IgG is only 1-3% carbohydrate, has only one carbohydrate
moiety at position 237, and Kornfeld found a different sequence of
sugars in seven IgG myeloma oligosaccharide chains (23).
proteins tested have more carbohydrate than IgG:

Other

alpha1-antitrypsin is

16%, and Ig~ is 7-12% with five carbohydrate chains (25).

But what

answers this question are the data which show 1) that both IgG Fab and
Fc fragments react with the antiserum and that the Fab fragment lacks
carbohydrate, 2) that trypsin digested Fab frag!11ent looses react ivi ty
to the antisennn, and 3) that reduced and alkylated IgG no longer
reacts with the antiserum.

Dales and coworkers have recently discovered monoclonal antibodies
with affinity for murine Thyl.l and Thyl.2 which also bind to actin and
vimentin

(26).

Th~~

compared amino acid sequences of Thyl.2, smooth

muscle actin and rabbit vimentin and showed suggested sequence homology
as we have done with human IgG.

In summary, we have demonstrated that an antiserum lmde to a human
T cell specific product, reacts with a B cell specific product.

We
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have tried to pinpoint the shared antigenic determinants between human
IgG and human Thy 1 through the use of antiserum reactivity, published

Thy-l sequence data, and biochemical modification of the human IgG
molecule.

Our conclusions of shared antigenicity can only be further

substantiated by determining the sequence of the human Thy 1 antigen
which is now in progress in our laboratory.
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Table I
5 1 Cr Release Cytotoxicity Assay with Rabbit Anti-Human p25
Antiserum Against T Cells

+

B.ALR/c Thymocytes
HPB-HLT
Molt 3
Molt 4
Jt~

Cll~

band

HPB-ALL
Molt 21

SB
HSB
CEM-pellet
W• M. (woolly m:>nkey
T cell)
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Fig. 1.

ELISA assay showing reactivity of the p25 antigen with the

anti-p25 antisera.
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Human ThyJ(p2S)

E

c:
po-

~

.500

+-

o

Q)

u

c:

o

.0
~

o

CI)

..0

«
~~--~----~--------------~----------~----~I/

40

80

160

Dilution of anti - p25 serum

500

1000

65

Fig. 2.

ELISA. assay

sho\olir1~~

with anti-p25 antisera.

react i vi ty of four h-LLT1an Ig:} molecules

1.000

•

• MOG IgG 3 A
A
A KGY IgG 1 k
0 - - 0 GAR IgG 1 k
•
• TIL IgG 2 k

·500

~--------~--------~~------~!
40

80

I

*

~

160

*Ig of chicken, sheep, COVJ, rhesus , baboon , gorilla, human CAN IgM , JOR
IgA, FOR IgA, ANT IgM, NEV IgM , ,L32-microglobulin
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Fig. 3.

Reactivity of rodent immunoglobulins with anti-p25 antisera.

1.000

.500

Mouse IgG

•
160

Fig. 4.

Reactivity of human IgG Fab and Fc fragments with anti-p25

antiserum.

a-p25
1.000

.500

HUS Fab

I

10

40

80

160
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fig. 5.

ELISA ass~ reactivity to human IgG after

(A) Reactivity of

four human IgGs with unabsorbed anti-p25 antiserum plus reactivity to a
control of normal rabbit serum.

(B) Reactivity to the IgG's with

anti-p25 antiserum absorbed with normal pooled human IgG.

(C)

Reactivity of human IgG to anti-p25 antisera after absorption with Molt

4 cells (lxl0 6 ).

(D) Reactivity of human IgG with acid vash of the IgG

coupled Sepharose 4B column as seen in B.

A.

B.
a. Unabsorbed a -p25 sera
b. Control (NRS)

1.500

Sera absorbed
w/human IgG
coupled to
Sepharose 48

1.000

1.000

.500

.500

~
20 40

b.

~
80

20 40

160

c.

160

D.
Sera absorbed
w/Molt 4 cells

1M Acetic Acid
wash of human
IgG-Seph 48

1.000

1.000

.500

.500

10

80

40

80

160

20

40

80

160

Fig. 6.

ELISA assay of anti-p25 reactivity to the p25 antigen after

absorption with Molt

4, absorption with human IgG coupled to Sepharose

4B, or 1M acetic acid wash.

p25 antigen

1.000
E

o

c

.1M Acetic Acid wash

~

r--

labsorbed with Molt i

~

.....

a absorbed with IgG

0

C1>
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unabsorbed antiserum
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a
...a
'-
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...a
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40

80

Dilution of anti-p25 serum
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Fig.

7.

Reactivi~

of trypsin digested, Staph

v-B

protease digested,

and intact IgG Fab fragment with the anti-p25 antiserum.

o Undigested MOG Fab

o
A

o Undigested KOR Fab
o Staph V-8 protease digested

Staph V-8 protease digested
Trypsin digested

A

1.000

1.000

.500
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40
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20

Dilution of antl-p25 serum

40

80
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Fig. 8.

Amino acid sequence surrounding disulfide bonds for the

constant domains of human IgG and the 9-112 disulfide bond of murine

Thy-I.
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-[nclosed boxes denote similarity to
murine Thy I disulfide bond
• ·Underlined are the amino acids that
are different in the rabbit

1 Fits

William and Gagnon ' s model

for murine Thy I

CHAPTER 4
BI OCHEMICAL CHARACTERIZATION OF THE HUMAN THY 1
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The human Thy 1 homologue was further characterized biochemically
by sequence and carbohydrate studies.

Two other forms of the human Thy

1 molecule were detected and partially characterized.

A 40,000 MW

molecule is the dimer of the 25,000 MW Thy 1 molecule and its formation
is increased by the presence of sodium dodecyl sulfate.

The second

form of 16,000 MW appears to be a cryptic or breakdown form of the
25,000 Ww human Thy 1 molecule.

INTRODUcr ION

The Thy 1 or theta antigen was first detected on nurine brain and
thymus as a cell surface alloantigen (1).
in micelle formation using detergent.

Thy 1 can only be isolated

Rat brain Thy 1 carbohydrate

composition has been determined (2) and the protein portion has been
sequenced (3), as has been done for mouse brain Thy 1
rodent

T~

(4,5).

The

1 has been shown to consist of approximately 111 amino

acids, it contains four cysteines and also contains three N-linked
sugar chains.

An unusual feature of the glycoprotein is the C-terminal

peptide, as it does not contain any extended sequence of nydrophobic
amino acids necessary for membrane anchorage (3).

Human Thy 1 (also designated p25) has been isolated from a hUJl1an
lymphoblastoid T cell line, nolt 3, and characterized by antigenic
studies using cross-reactivity and immunoabsorption experiments with
mouse Thy 1.2 (6).

Human Thy 1 has the same rnlecular weight as its

murine counterpart according to SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) (7).

The human Thy 1 molecule was

found to be similar though not identical to its murine
peptide mapping and amino acid composition.

The

s&~e

ho~ologue

~J

types of

comparisons have been made and similar conclusions drawn using

T~y

1

glycoprotein isolated from human brain and fibroblasts (8).

In our present studies, we have detected two other forms of the
human Thy 1 antigen.

One fonn is approximately 40,000 daltons in MVl

(molecular weight) a c cording to SDS-PAGE and is designated p40 and the
other is 16,000 daltons MW, designated p16.

Both forms are reactive
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with antisera made to the human Thy 1 or p25 antigen.
seem to have al.most identical amino acid canposi+, Lons.

~he p40 and

p25

The amino acid

~he carbohydrate

compos ition of the pl6 is also very similar.

composition of the p40 and p25 are similar while the p16 seems to have

less carbohydrate.

HPLC (high-pressure liquid chrorn.e.. tography)

chroroatograms of tryptic digests of the p4 0 and p25 in their nnnaneric
The p16 tryptic peptioe

and in their aggregated formE are identical.

chromatogram is di fferent but seems to contain a nUMber of ident ical
+-.~

pep v1 11es.
,~ ed
p40 crea ~..

Ther-efore, the p25 antigen appears to form as a di;ner
d"r~·
'-.A
_

n.. 1

g 1·so'l at,.1·on;·1 ts
_

_

n
t"10n
IOrma

1S

l
ted b y expo sure
a CC e-Lera.

to SDS; and the ':'hy 1 may also exist in a breakjo-"TT1 form that is
possibly pre s e nt

o n the cell surface.

t~1e
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MATERIALS AND METHODS
Isolation:

Molt 3 cells were grown according to procedures described

previously (9) and isolation of the p25 antigen was performed as
described previously (6) with the following modifications.

After

elut ion wi th 3% a1pha-:nethyl mannos ide of the Sepharose 4B Lens culinaris column (Vector), the bound fraction was applied to as-200
Superfine column and the low molecular weight (LMW) fraction ~s
applied to a preparative SDS-PAGE and extraction of protein
performed as described previously (7).

~s

The purified protein w.as

concentrated by lyophilization and applied to a 12 cm x 0.5 cm Sephadex
G-25 column in distilled water.

This step was deemed necessary in

order to remove contaminating glycine from the Tris-glycine SDS-PAGE
and other contaminants w.hich interfered with carbohydrate analysis (See
Figure 1).

In one isolation procedure the preparative SDS-PAGE was fixed in a

50% Trichloro-acetic acid (TCA) , 0.1% Coomassie Blue solution.

The

25,000 and 40,000 MW bands were excised and the protein extracted from
the gel as described previously

(7).

The 25,000, 40,000 and 16,000 MW material -was also isolated from an
immunosorbant column prepared essentially according to the method of
Marsh et al. (10).

The 1r-1 glacial acetic acid fraction was applied to

a preparative SDS-PAGE and the protein extracted as previously
dese ribed (7).

n
Analytical SDS-PAGE was performed according to the method of
Laernmli (11), us ing a l~ or 12.5% gel on a Hoefer electrophoresis
apparatus.

The gels were stained with Coomassie Blue.

If the bands

were not visible by this stain, the gel was subsequently stained by the
silver-nitrate method (12).

Complete reduction of proteins was performed by addition of 10%
B-mercaptoethanol and heating at 100°C for 5 min. in a heating block
before application to SDS-PAGE.
Production of Antisera:
previously (6).

The antisera was raised as described

Briefly, rabbi ts were inj ected intramuscularly with

the p25 antigen in complete Freund's adjuvant.

Second and third

injections followed 14 and 28 days later with incomplete Freund's
adjuvant.

Enzyme-linked Immunoadsorbant Assay, (ELISA):

This ass~ was

performed as described previously (13).

Amino Acid Composition:

r::'he amino acid (a.a.) compositions of purified

p40, p25, and p16 antigens were analyzed

qy

Durrum D-500 automatic amino acid analyzer.

standard procedures using a
Approximately 50 ug of

protein was 1vdrolyzed in 6N HCI, 0 .1,% phenol at 110°C under vacuum for

18 hrs.

Sperm whale myoglobin was used as a control and to correct

a.a. composition calculations as described previously (7).
Peptide Graphs of Tryptic Digests on HPLC:
performed as described previously (7).

Tryptic digestions were

Separation of peptides was

accomplished on a Waters High-Pressure Liquid Chromatograph, using an
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ODS-Hypersil reverse phase column (Altex) essentially according to the
parameters of Yang et ale (14).

A linear gradient was run using a pH

2.14 triflouro-acetic acid in distilled water as Buffer A and a 40%
buffer A and

60%

acetonitrile as Buffer B.

The gradient

~s

increased

from 0-70% over 50 minutes at a flow rate of 1.5 ml/min while
maintaining the colUMn temperature at either 45°C or 60°C.

The eluate

was read at 220 nm using a Kratos variable wavelength
spectrophotometer.

Carbohydrate Composition:

Identification and quantitation of neutral

and amino sugars was determined by the Rldito1 acetate method (15,16).
Percent carbohydrate calculations were made according to the formula of
Sloneker (17).

Gas chromatography was performed on a Hewlett-Packard

Model 5830A gas chromatograph equipped with dual flame ionization
detectors.

A 6 ft x 2 mm glass column packed with 3% SP-2340 was used.

Injection temperature was 250°C and detector temperature was 350°C.
Initial temperature was 190°C, held for 6 min then raised to a final
temperature of 240°C at a rate of 1.7°/min. and held for 20 min.
carrier gas was nitrogen at 20 ml/min.

Peak areas

~re

The

measured and

integrated by a Hewlett-Packard 18850A GC terminal.
Approximately 100 ug of the samples V+O, p25, and p16 were qydrolyzed in 0.5 mls of 3N HCl at 80°C for 16 hrs.
extracted 3X with 0.5 ml of n-hexane.
internal standard.

The samples were

Inositol acetate

~s

added as an

The sample was incubated for 1 hr at room tempera-

ture after the addition of 0.5 ml of IN NH40H containing 2 mg NaBH4.
The boric acid was then neutralized with acetic acid (app. 7 drops).

19

One ml of methanol:benzene (5:1) + 50 ul acetic acid ~s added to the
sample and it was incubated at 80°C for 5 min. and then evaporated
under nitrogen.

This step was repeated 4x without benzene.

The sample

was completely dried and acetylated with 0.15 ml acetic anhydride at
100°C, under nitrogen for 1 hr, after which 0.5 ml of chloroform was
added to the sample and extracted 5X with 0.5 ml distilled water.

The

sample was dried and reconsituted in an appropriate volume of chloroform fo r inj ect ion.

Cyanogen Bromide Cleavage:
dissolved in 20 ul of

1~

Approximately 20 ug of the p25 antigen was
formic acid, after which 20ul of a cyanogen

70%

bromide solution (25 mg Cnbr/l ml
s~~ple

formic acid) was added.

The

was incubated at room temperature for six hours at which time 1

ml of distilled water was added and the sample was lyophylized.

Amino Acid Sequence Determination:

N-terminal amino acid sequences

were determined by Edman degradation with a Beckman Hodel 890 C
automatic protein sequencer using a 0.1 M quadrol buffer.

Identifica-

tion of amino acid phenylthiohydantoin derivatives was carried out with
a Dupont high pressure liquid chromatograph.
Immunoblot Technique:

Immunoblotting was performed essentially

according to the method of Tsang et ale (18) with rodifications in the
staining procedure.

Briefly, a DOC and a SDS solubilized

preparation of Molt 3 cells
gel.

~re

membr&~e

electrophoresed on a 1.5 rom thick slab

The gel was then traDsblotted against a nitrocellulose transfer

blot (Bio-Rad) overnight at 300 rna at 4°c in blotting medium, 0.025 r~
Tris, 0.193 t-1 glycine, in 2Cf/o methanol.

The nitrocellulose was washed
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3X with 1~ gelatin in PBS for 15 min. and then the anti-p25 antibody
(1:100 dilution in 1~ gelatin) was appliei for 2 hrs under gentle
shaking.

~he blot was then washed once in 1% gelatin/PBS and the

secondary antibody [Goat anti-rahbit horse-radish peroxidase couplect
(Cappel) 1:1000 in l~ gelatin] was applied for 2 hrs.

The blot was

then washed in PBS 2X for 15 min before applying the substrate, 0.05% 4
chloro-l-napthol in PBS plus 0.1% H202 (3%) for 20-30 min.
was then washed with H20 and air dried.

The blot
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RESULTS
The major band seen after isolation of the LMW peak from the S-200
Sephadex column was the p25 (see Fig. 2A).

Concentration of the p40 and

the p16 vary from preparation to preparation from undetectable to
10-20% of total protein.

Desalting on the small Sephadex G-25 was

found necessary in order to remove glycine and other contaminants Which
interfered with amino acid and carbohydrate compositions.
As can be seen in Table 1, the a .a. composition of the p40 and p25
are almost identical" as is the p16, though slightly different.

These

compositions are very similar to those reported for rrouse Thy 1 (4),
rat Thy 1 (2) and human brain Thy 1 (8).

By using the method to

determine relatedness among proteins of Marchalonis and Weltman (19)
vhich is based upon statistical analysis of differences in amino acid
composition, we determined that the p25 and p40 are most closely
related to the murine Thy 1 (see Table 2).

The p25 a.a. composition

was compared to that of 168 other proteins of which those proteins
shown in Table 2 are representative.

Figure 3 shows the relative migration distance of the p40 and the

p25 on a 12.5% SDS-PAGE stained with Coomassie blue.
The ELISA assay showed that all three antigens are reactive to
antisera made against the p25.

The p40 is more reactive than the p25

which is in t urn more reactive than the p16 to antisera made to the p25
antigen as shown in Figure

4.

When the p25 and the p40 were run on a preparative SDS-PAGE and
then fixed in the TCA-Coomassie blue fixing solution, then extracted,
and rerun on a 1 Cf/o analyt ical SDS-PAGE, both Il'Olecules migrated
identically.

As can be seen in Figure 5, the now aggregated p25 and

p40 migrated at an approximately 110,000 HW range.

When the aggregated p25 and aggregated p40 were treated with a
reducing agent, 8-mercaptoethanol, both reduced to the p40 form of
identical migration on SDS-PAGE (Figure

G).

When the p40 molecule is

reduced it is not converted to the p25 form (data not shown).

The

relative migration of the p16 molecule is shown in Figure 6d.

Some

microheterogeneity is seen as is characteristic of glycoproteins.

When the P40, p25, and p16 were digested with trypsin and run on
high pressure liquid chromatography at 60°C, the chromatograms appeared
very similar for the p40 and the p25, yet, slightly different for the
p16 (Figure 7).
expected

HPLC

i~

Twelve to fourteen peptides are seen as would be

a tryptic digest of the Thy 1 antigen.

chromatograms of tryptic digests of the aggregated p40 and

aggregated p25 also revealed the identical nature of these mlecules
(Fig. 8).

The tryptic peptide maps of the Aggregated molecules appear

different from those of the non-aggregated molecules.

This is because

the aggregated maps were run ill1der a temperature of 45°C "While the
non-aggrega t e d rna t erl·al s were

iLln

at 60°C.

induced the peptides to be eluted sooner.

The increased temperature
The approximate number of

12-14 peaks remains the same for all proteins.

Amino acid sequence determination of approximately 2 nmole of
reduced and alkylated p25 revealed no PTH amino acid.
n-terminal amino acid of the nnlecule is blocked.

It is likely the

Sequence

determination of a cyanogen bromide peptide of p25 revealed a serine at
the amino terminus.

Carbohydrate analysis was performed using 100 ug of the p40, p25,
and p16 antigens.

Th e antigens were desalted on the G-25 Sephadex

column before running on gas chromatography.

Table 3 shows that the

percentages of the mannose, galactose, glucose, and glucosamine are
similar for the p40 and p25 antigens.
p16 were quite different with no

However, the percentages for the

glucosa~ine

detected.

The presence of SDS seems to convert the p25 to the p40 molecule.
In order to prove p25 conversion to the p40 form was induced by SDS, a
membrane preparation of Molt 3 cells was dissolved in either 2.5% DOC
or 2.0% SDS 10 mt-1 Tris-Rel.

The immunoblot showed p25 and p4D in the

DOC preparation and the absence of p25

vith greater amount of p40 in

the SDS preparat iO!1 along -wi th act in and some high molecular weight
material, perhaps the 110,000 MW aggregate (Figure

9).

Molt 3 membrane preparations solubilized in DOC showed the presence
of p25 by immw10blot, however the same preparation solublized in SDS
did not show any detectable p25 (Figure 9).
and assumed aggregated material.

Both contained p40, actin,

The anti-p25 serum has been shown to

be slightly reactive to actin (manuscript submitted).

In a membrane

preparation, actin is present in a much greater amount than the p25
molecule, therefore appearing as a much darker band on the immunoblot.
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DISCUSSION
The Thy 1 molecule is a glycoprotein found on rodent
lymphocytes, neuronal cells, and fibroblasts.
as a marker for T cells in mice.

t~mocytes,

T

It has long been known

The molecule has been sequenced in

the mouse and rat brain and characterized according to the carbohydrate
moieties (2-5).

Homologues have been found in man (6,20), dog (21),

and chicken (22).

However, the antigen still remains a puzzle in

several respects.

For example, although predominantly found on

neuronal cells, the expression of Thy 1 on lymphoid cells varies
according to species.

Thy 1 is abundant on mouse and rat thymocytes,

and present on mouse T lymphocytes, yet absent from rat T lymphocytes
(2).

At present, there is a great deal of confusion and disagreement

in the literature as to Where Thy 1 can be found in the human, and
whether it is present on human

tl~mocytes

or T lymphocytes at all.

According to McKenzie and Fabre (23) it is only present in discrete
areas of

t~mus,

spleen, and lymph nodes, but according to Balch and

Ades (24), it is expressed on thymus and peripheral T lymphocytes.
This discrepancy is probably due to the specificity and method of
production of antisera in each laboratory.

These differences can only

be res o lved by isolation of the antigen from the tissues in question,
followed by biochemical characterizat ion of the isolated antigen.

We have shown in previous work (6) that the p25 antigen isolated
from Molt 3, a human lymphoblastoid T cell line, is antigenically
cross-reactive with mouse Tny 1, has a similar molecular weight, binds
to Lens culinaris lectin, has a similar amino acid composition, and is

similar by peptide mapping, though not identi c al (,).

Present st nd i e s

i n die Ft t e t hat the p2 5 has 12 -1 4 t ry p tic pe P tid e s w71 i chi s s im i 1 R. r to
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a:pp~oximat~ly 20%

the p25 is

cartohydra.te 'Wt-l i c h is similar t o rode:1t Thy 1

(3,5,20); and se q uen c e st l~ dies s :l.gge s t that the R.G1ino te~IJ inus is
blo c ked b j' a pyro-gl"..ltHIna te as i s present in t h e r odent :I'hy l

(3 , 5) .

An-lino acid sequenci ng of a peptide created by treutr:'1ent of the p2 5
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exposure to SDS and is therefore a product of isolation.

The dimeriza-

tion of the p25 to the p40 form could not be due to disulfide-bond
interlinkage because it is not reduced by mercapthoethanol.

Perhaps a

hydrophobic moiety on the molecule is causing the dimerization.

We do

not know whether the p40 can be found on the cell membrane.

Ours is not the first study to detect mole cules of di ffering
anti-~hy

molecular weight which are reactive to

1 antisera.

Saj i and

Tanigaki (25 ) isolated a Thy 1 like antigen fran a human T-cell
leukemia cell line SKW-3 .
and another of 110 ,000

~1;':

'I'hey detected a najor component of 30,000 MI.J
·which reacted wi th their rabbit

made against a Molt 3 glycoprotein .

antise~um

Our reduced and alkylated p25

antigen also migrates at approximately 29,000 MW on SDS-PAGE.

Perhaps

t}lis 110,000 M"w molecule is related to the aggregated p25 and
aggregated p40.
absence of

Cau~er
~.J
~

(26)

Kuckel reported

a 230,000 ~w for rat Thy 1 in the

deox~cholate.

~nj
i::i
l

Co-l'n\re
c--- +l"o
~ +O~s
..
v
0 Cl.
v
•

7
l"n 10
./ i 4\

7
(0
\
I
L-

.)

protein from Swiss n.lbino murine tJ-lymocytes.

isolated a 40,000
~TIen

this protein

injected into .AKR r1ice, anti-theta alloantiserurrl was produced.
40,000 t,fvl protein

W'8.S

iS 8 1ated in the following

1Y1J.8..nner .

M"I'IT

"WaS

This

A membra.ne

fra.ction was stabilized in a Tris-B e l, 2't SDS buffer anj centrifu.gej.
~he

supernatant w. s appl ied to a Seph adex G-200 coluJ"'l.D and the

fractions were dialyzed against distilled water.
accepted PY'otocol of isolation

0:

~his

differs

fro~

the

murin e Thy 1 which includes

dissolving thememt) rane fraction in a 2.5~ DOC Tris-HCl buffer,
centrifugation, and the superna~ant applied to a 2-ectin column (usually
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lens culinaris) and then gel filtration.

We pr~ose that utilizing

different solubilization techniques and a different detergent, SDS
instead of DOC, causes the murine Thy 1 to dimerize to a 40 ,000 MW.
Support for this proposal comes from immunoblots of Molt 3 membrane
preparations using either SDS or DOC.

In contrast to the DOC

preparation, no p25 was detected in the SDS preparation.

Since Thy 1 is found on neuronal cells at synaptic junctions of the
brain and since T lymphocytes are regulators, i.e., helpers and
suppressors of the immune system, Thy 1 could be functioning in
cell-cell cOMmunication.

Seeds and his coworkers (28) have correlated

the presence and absence of Thy 1 wi th the presence and absence of
synapses in cuI tllres of brain aggrega tes.
have shown that

anti-T~v

behavioral responses.

Willi ares and his group (29)

1 sera applied to brain can affect rat

These antibodies also inhibit virus-dependent

proliferation of leukemia cells (30).

~

comparing sequence homologies

of rat and mouse Thy 1 with immunoglobulin domains, HLA antigens, and
b 2 microglobulin, Williams and Gagnon (5) have proposed that the Thy 1
is the best candidate for a molecule which may approximate the
primordial immunoglobulin domain.

Thy 1 could function as a receptor

for another molecule or one could argue that Thy 1 is a ligand to be
recognized by receptors on other cells.
Since the p16 antigen reacted to antisera and possessed similar
amino acid composition to the p25 antigen, it is possible that the
different migration on SDS-PAGE could be due to reduced amount of
carbohydrate.

The nolecular weight of rodent Thy 1 has been determined
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to be 17-18,000 daltons by sedimentation equilibrium studies (26) and
to be approximately 20-3a% carbohydrate

(2,4).

It is because of this

increased carbohydrate content, wh ich affect s the mass/ charge ratio of
the molecule, that the Thy 1 appears as 25,000 Ww on SDS-PAGE.
carbohydrate

~s

If

reduced, the p25 molecule could theoretically migrate

in the area of the p16 molecule.

Carbohydrate analys is did not show the p25 and p4 a to be ident ical,
yet this is wi thin the range of error for this type of analys is.

~he

p16 antigen possessed conside rably fewer sugar residues compared to the
p25.

~his p16 a~tigen

is ass~~ed to be the pI6 antigen found on

suppressor cells by Balch and coworkers (24,31).

They prepared an

anti-r:1onkey thyP.1ocyt e serum which recogn ized a 25 ,000 and a 16,000 MW
ant igen.

~he 8.ntis~rum

'Was absorbed with Molt

4 , a T lymphoblastoid

cell line which possesses the p25 but not the p16 antigen, thereby
making the antisera specific for the p16 antigen.

Using the pokeweed

rni togen immunoglobulin-indtlction assay, they showed that a detergent
soluble 16,000

M\o,T

a!1tigen was expressed on h . unan suppressor T lympho -

cytes and minimally on helper r:r lympho cytes .
25 ,000

~Fd

Agthoye~1 (32)

found a

protei:1 associated wi th the T-3 antigen, a 19 ,000 MIt: protein,

after tritiated

~abelling

immunopr ecipi t 2~t ion.

of human peripheral blood T lymphocytes and

Bors t and cowo rke rs (33) found four di st i nct

glycoproteins associated wi t"h the T-3 antigen irmnunopre c ipit.qtes from a
hunan leukemia cell line HPB-ftLL.
"..re ight of 25 -23 ,0 00 f,fw

One of the complex had a molecular

by SDS-PASE and after deglycosylation wi th

Endoglycosidase? had an apparent molecular weight of 16,000.
~herefore this JOOlecule has a If;-k dalton protein backbone and carries

only N-linked, complex-type carbohydrate.
The p16 could be a cryptic antigen, i.e., part of the p25's
structure removed Qy some form of enzymatic degradation.

Could it, the

Thy 1, be processed in the cytoplasm and inserted in the membrane
without the attachment of carbohydrate?

Does the p16 antigen Playa

role in suppressor T cell function or is it merely co-expressed and
present as a breakdown product on older T lymphocytes?

These questions

remain to be answered, and mayor may not aid in determining the
function of the Thy 1 molecule.
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Table 1
Amino Acid Compositions
Approximate amino acid composition of
p40 and p16 as compared to that of p25.
Compositions are expressed in mol%;
tryptophan and cysteine are not included.
Values marked with a star are corrected
values. Actual values were higher due
to inadequate desalting procedure.

Amino Acid

ASX
THR
SER
GLX

PRO
GLY

ALA
VAL
MEr
ILE
LEU
TYR
PRE
HIS
LY8

ARG

p25

p40

p16

12.0
6.3
6.2
13.4
5.9
3.1
5.7
8.0
1.4
4.2
9. 6
2.6
3.6
1.8
7.9
4.8

11.6
6.7
5.5
13.7
6.6
3.0*
5.0*
6.3
1.3
5.5
9.6
3.0
3.6
2.0
7.9
4.5

11.3
6.4
6.6
11.9
3.8
3.8*
4.8*
7.0
1.5
5.6
9.9
2.5
4.1
2.6
8.1
5.6

Table 2
Comparison of HUJl1Rn THY 1 to Various Proteins Utilizing SIlQ Calculations

Prot ein

S~(~

Mouse Thy 1.2
Rat Thy 1.1

3h

p40 antigen
p16 antigen

7
13

Hum.an heno£lobin
Human 82mic roglo hul in
Human HLA B-27
+ .:
Human C-re active prove..i..n
Nerve Growth Factor
Actin
Human Serum Albumin
Cytochrome C
Lysozyme
Ribonuclease

49

184
5· 5
13 5

78
198
90

72
197
224
268

Protei!1

SllQ

Kappa variable region
Lambda variable region
Heavy variable region
Kappa constant region
Lambda constant region

173
228
148
151
181

CHl OU

HUP1B.n
H"".lman
HUIn.a.n
HUr.1an

Ih2
142
210
134

CH2
CE3
CH4

Human CAJ ~
Human garmra

110
114

Human .T chain
HUP1an complement component

147
65

(

..'

c4

Calculations were performed according to the method o f I\1archalonis and Weltman
(19). This method determ in e the relatedness among proteins based u}X)n
statistical analysis of differences in a.a. composition. Results have been
shown to correlate closely wi~h comparisons based on the sequence of related
prot eins.

Where i and k identify t "he pa.rticular pr oteins which are being compared.
the content of a give n amino acid of type j .

Xj is
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Table 3

% Carbohydrate Composition

p+o

p25

fucose
rnannose
galactose
glucose
glucosamine
galactosamine
sialic acid

0
5~4%

(8.3)

1.0 (1.8 )

1.R
.5

p16

0

0

4.8% (7 .3)
2.2 (4.0)
3.3

4.3% (6.6 )
.2 ( .3)

.6 (1.8 )

(1.4 )

1.2
0

0

0

0

N.D.

N.D.

N.D.

Numbers in parenthesis are ca r bohydrate residues using
published carbohydrate canposition for ell anti-tryps in
as a correction factor (33).

Figure 1.

Flow chart of isolation of Human Thy 1.
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Figure 2A.

Densitometer tracing of a silver-nitrate stained 12.5%

SD8-PAGE of the LMW fraction from 8-200 8ephadex column.

B.

Same as

above except this sample came from a recycled rnannoside elution of the
lentil lectin column.

Mainly the p16 band is seen.
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Figure 3.

A 12.5% SDS-PAGE of the (a) p40 molecule and (b) p25

molecule stained with Coomassie blue.
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<

o.

b.
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Figure 4.

Results of Eliza ass~ showing the reactivity of the p40,

p25, and p16 to rabbit anti-p25 antiserum.
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Figure 5.

A 10% SDS-PAGE gel stained with Coomassie blue showing the

aggregated p25 (a,b) and the aggregated p40 (c,d) as identical bands at
approximately 110,000 MW position, as shown by the HMW standard (e) and
LMW standard

(r).
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Figure 6.

A 12.5% SDS-PAGE stained with silver-nitrate stain showing

the (a) LMW standard (b) completely reduced aggregated p25 (c)
completely reduced aggregated p40 and (d) p16 nolecule.
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Figure 7.

Tryptic peptide graphs from HPLC of the p40, p25, and p16

antigens.

The column temperature was maintained at 60°C.

p40
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Figure 8 .

Tryptic peptide graphs from HPLC of the aggregated p25 (a)

and the aggregated p40 (b) ITOlecules .
tained at 45°C .

The column temperature was IIBin-
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Figure 9.

An nitrocellulose

~unoblot

showing (a) the DOC membrane

preparation and (b) the SDS membrane preparation.
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CHAPTER 5
A 40,000 M.W. HUMAN THYMUS GLYCOPROTEIN RELATED
TO HUMAN THY 1 HOMOLOGUE
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SUMMARY
A 40,000 M.W. glycoprotein was isolated from' human tQymus.

This

molecule binds lentil lectin, reacts with an antiserum made against the
p25 antigen (the human Thy 1 homologue) and possesses almost identical
amino acid composition as the p25 antigen and its 40,000 H.W. dimer.
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INTRODUcrION
The Theta or Thy 1 molecule

~s

described originally as a murine

brain and thymus antigen by Reif and Allen in 1964 (1).

It has since

served as a cell surface differentiation marker for tlvmocytes and
mature T lymphocytes in mice (2).

In rats, Tny 1 appears earlier in

development than in mice with the antigen being present, in addition to
brain and thymus, on bone marrow (2) and haemopoietic cells (3), but
not on peripheral T cells (4-6).
The Thy 1 antigen exists in similar quantities in human brain as
compared to rodent brain (7); however, controversy exists concerning
the existence of Thy 1 on human thymus (8-10).

Dalchau and Fabre did

not detect Thy 1 on human thymocytes in 1979 (11), but McKenzie and
Fabre did detect Tny 1 in di s crete areas of the thymus in 1981 (12),
using an antiserum prepared against a human brain Thy 1 antigen.

Balch

and Ades (13) detected a 25,000 M.W. membrane antigen using an
antiserum prepared against monkey thymocytes localized on normal T
lymphocytes and human T lymphoblastoid cells.

Ritter (14) found human

Thy 1 present on 0.1-0.5% of bone marrow cells and 0.2-10.0% of
thymocytes, with all Thy 1 positive T cells situated in the outer
thymic cortex.
After isolating a 25,000 M.W. glycoprotein from the M)LT-3 human T
lymphoblastoid cell line and determining its homology with the murine
Thy 1 molecule, we attempted to prove the presence or absence of this
glycoprotein on human thymus.
of whether the 25,000 M.W.

Also of importance was the determination

molecule isolated from the lymphoblastoid
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cell line was similar if not identical to that found on normal tissue.
After using the

~pical

isolation procedure for murine and human Thy 1,

little 25,000 M.W. glycoprotein was detected.

However, a 40,000 M.W.

glycoprotein with characteristics similar if not identical to the human
Thy 1 was detected.

In a previous study

we

found that the human

T~

or p25 molecule seems to form a dimer of approximately 40,000 M.W.
(Bonewald et al., submitted for publication).

The 40,000 M.W.

molecule isolated from human thymocytes is a glycoprotein, i.e., it
binds to lentil lectin, reacts with antisera made against the p25
antigen, and possesses an almost identical amino acid composition as
the human Thy 1 and its 40,000

t~. W.

dimer.

1

III

MATERIALS AND METHODS

t~us

Normal

gland was obtained from patie nts aged 6 months to 12

years who had portions of this gland removed as a necessary adjunct to
cardiac surgery.

The thymic fragment was immediately placed in saline,

transferred to l640-RPMI (Gibco), the outer membrane removed, minced by
scissors, and pressed through a nylon mesh bag into a single cell
suspension.

Red blood cells were removed by lysis in a 0.85% ammonium

chloride solution and the cells washed in phosphate-buffered saline
(PBS) and frozen until enough material was collected for isolation.
Molt-3 cells were grown and harvested as described previously

(15,16).

Bovine muscle actin was purchased from Sigma.

Isolation procedure
Thymocytes were subjected to one of three isolation procedures:
one is the standard procedure for the isolation of rodent Thy 1, one is
an abbreviation of this procedure, and one is passage over an
immunosorbent column.

The standard isolation procedure is shown in

Figure 1.
In the second procedure, the material which bound to a lentil
lectin column and that which did not bind was subjected to preparative
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as
described previously (16).
The third isolation procedure was identical to the previous
procedure to the point of micelle formation of membrane glycoproteins
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in the 2.5~ DOC supernatant.

This material was applied directly to an

immunosorbent column prepared using rabbit anti-p25 antisera (17).
After application, the column was washed with PBS.

The bound antigen

was eluted using 1 M acetic acid, after Which this material was air
concentrated.
Preparation of immunosorbent column.

10 g of Sepharose 4B was

activated by cyanogen bromide essentially as according to the method of
March et ale (18) and reacted with 5 ml of rabbit anti-p25 antiserum.
Enzyme-linked immunosorbent assay (ELISA).

This ass~ was performed as

described previously (19).
Amino acid composition.

The thymocyte antigen, the p25 antigen, and

actin were analyze d for amino acid composition by standard procedures
using a Durrum D-500 automatic amino acid analyzer.

Approximately

20-50 ug of protein was hydrolyzed in 6N HC1, 0.1% phenol at l10 0 e
under vacuum for 18 hr.
SDS-PAGE.

Analytical SDS-PAGE was performed according to the method of

Laemmli (20) using a 12.5~ gel on a Hoefer electrophoresis apparatus.
The gels were stained by the silver ni trate TIEthod (21).
Gel densitometry.

Gel scanning was performed using a Joyce-Loeble

Microdensitometer 3CS (England) with a 15.8 rom slit and a

446 filter

of the film positives made of silver nitrate stained polyacrylamide
gels.
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RESULTS
When human

t~ocytes

were subjected to the identical isolation

procedure as used for the isolation of rodent Thy 1 or human Thy 1,
little or no 25,000 M.W. bands were seen in the LMW fraction of the
8-200 superfine column.

These results can be seen in densitometer

tracings of 12.5% SDS-PAGE as shown in Figure 2.

The LMW fraction from

Molt-3 cells contains a great deal of the 25,000 M.W. or p25, with
smaller amounts of bands at the 40,000 and 16,000 M.W.

area.

~he

thymocyte fraction showed no major band.
For the next isolation procedure on human thymocytes, the lentil
lectin eluted fraction was not applied to the S-200 column.

Instead

the material which bound to the lentil lectin and the fraction which
did not bind to lentil lectin were air dialyzed and subjected to
preparative SDS-PAGE.

These different fractions were tested in the

ELISA assay for reactivity to the anti-p25 antiserum.

As shown in

Figure 3, only one fraction (fraction #4, corresponding to
approximately 40,000 ~1.W., bound to lentil lectin) reacted with the
antiserum; none of the unbound fractions reacted.
Next this bound fraction #4 was reduced and alkylated and reapplied
to a preparative gel.

A band of approximately 40,000 M.W. still

reacted with the antiserum (data not shown).
To decide whether this 40,000 H.W. band was actin, we performed
amino acid composition of bovine muscle actin, ran gels comparing
migration of the two proteins, and performed an ELISA assay to detect
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any reactivity of the p25 antisera with actin.

As shown in Figure 4,

there is moderate reactivity of actin with the anti-p25 antisera.
However, according to SDS-PAGE the actin migrates in the 45,000 to
47,000 M.W. range, and a band corresponding to actin is not detected in
the material that we isolated (Fig. 5).

Our amino acid compositions of

actin correspond very favorably with that reported by Tonarnura (22).
As shown in Table 1, the amino acid compositions of the human p25
isolated from Molt-3 cells and the 40,000 M.W. protein isolated from
human tnymocytes differs clearly from that of actin.

The key amino

acid which demonstrates a distinct difference between the two proteins,
actin and Thy 1, is methionine which is of considerably higher amount
in actin.

For the third i solation procedure, the human

t~mocyte

2.5% DOC

supernatant was applied to a rabbit anti-p25 immunosorbant column.
When samples were taken

~ediately

from the 1M acetic acid elution and

electrophoresed on analytical gels, two bands corresponding to
approximately 25,000 and 40,000 M.W.

were seen and appeared identical

to those seen with the same Molt-3 fraction (Fig.

6).

However, after

this wash had been pooled and concentrated by air dialysis at 4°c over
several days and rerun on gels, the lower band had disappeared in the
thymocyte concentrate but not in the Molt-3 concentrate (Fig.

7).

To

determine if the tqyIDocyte 40,000 M.W. band migrated in the same
position as the Molt-3 40,000 M.W. band, the further concentrated
samples were run simultaneously on a 12.5% SDS-PAGE.
that the two bands migrate identically.

Figure 8 shows
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DISCUSSION
The

T~r

1 antigen is probably the most abundant cell-surface

molecule found on mouse and rat thymocytes.

Reif and Allen (1) found

Thy 1 antigen is in greatest amount on murine brain and thymus,
followed by lymph node and spleen, but none on bone marrow.

Acton and

coworkers (4) found the Thy 1 antigen on rat brain and t~mus, on
spleen and bone marrow, but none on lymph node.
found canine Thy 1 on brain, kidney,

t~mus,

Dalchau and Fabre (11)

lymph node, spleen, and

bone marrow, but found human Thy 1 only on brain and kidney.

Although

the Thy 1.1 alloantigenic determinant (which differs by a single amino
acid substitution from Thy 1.2 in the mouse, arg for 1.1/gln for 1.2)
is found in the rat, the 1.2 is not.

Neither determinant is shared by

canine or human Thy 1 (11).
Arndt and Thiele (23) used anti-human brain antisera absorbed by
standard methods and by demonstrating cross-reactivity between species
showed little or no reactivity with human tqymus.

McKenzie and Fabre

(12) using an anti-human brain monoclonal antibody showed that hUMan
thymus, spleen, and lymph node contain Thy 1 positive components in
discrete patches.

Saji and Tanigaki's (24) Thy I-like antigen was

found in greatest quantity in brain, followed by testis, but also was
found in all lymphoid tissues, including peripheral blood.
Recently, Ritter et ale (14) found human Thy 1 present on 0.2%-10%
of thymocytes in addition to bone marrow, 0.1-0.5%.

Their data

demonstrated that Thy 1 is present on early stages of both T and B
lymphocytes.

Their antisera included a rabbit anti-rat brain Thy 1 and
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seven monoclonal antibodies to human brain Thy 1.

Ades and co-workers

(13) used an antiserum proe pared against monkey thymocytes to identify a
25,000 dalton surface protein on normal human T lymphocytes.
fore~

There-

confusion continues to exist concerning the presence or absence

of Thy I on human thymocytes and T lymphocytes.
For our detection

method~

we have used standard isolation

procedures for the theta antigen (25~26) and an tmmunosorbant column
made with rabbit anti-p25.
human lymphoblastoid cell

The p25 is an antigen purified from a
line~

Molt-3.

This replaces the serological

oirnmunosorption experiments used by previous investigat ors.
In a previous paper (Bonewald et al.~ submitted for publication)~
we have shown that the human Thy 1 or p25 antigen can be converted to a
40 ,000 M. W.

protein, especially after exposure to SDS.

Sauser et ale

(27) using SDS for detergent and a solubilization agent of a cell
membrane f'raction from mouse thymocytes, isolated a 40,000 M.W. Thy 1
antigen.

This is in contrast to the 25,000 M.W. Thy 1 isolated using

DOC as the solubilizing agent (7~25,26,28).
Only two pieces of our data show that the Thy 1 may exist in a
25,000 H.W.

form on human thymocytes.

One is the 25,000 M.W. peak

seen on gels immediately after the 1 M acetic acid elution of the
anti-p25 column.

The second is a faint band in the area of 25,000

daltons on the LMW fraction of the S-200 column.

Therefore, if the

25,000 M.W. protein is present on the cell surface it is rapidly
converted to the 40,000 M.W. form during isolation.
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In previous work, we established that SDS could convert the p25 or
Thy 1 to a 40,000 form, but from the present data it seems that acetic
acid may also cause conversion.

The thymocyte roolecule may be particu-

larly susceptible to this transformation.

Since the amino acid compo-

sitions appear similar, perhaps differences lie in the carbohydrate
content which could influence susceptibility to conversion.

Hoessli et

ale (29) determined that T-lymphocyte differentiation in the mouse is
accompanied by an increase in Thy 1 sialic acid by neuraminidase
determinations.

Carlsson and Stigbrand (30) demonstrated carbohydrate

complexi ty in the rrouse thymocyt e Thy I by lect in affini ty and
i soelect ric fo cus ing.
The most pressing question after discovering reactivity of our
·antiserum with the 40,000 M.W. fraction was
actin?

~-

could we be detecting

Actin is a highly conserved protein found in abundance in all

eukaryotic cells.

The amino acid sequence and composition is highly

conserved and it mainly plays a role in muscle contraction.

Although

actin could be a minor contaminant, our amino acid compositions prove
that the

t~mocyte

molecule being detected is not actin.

Also, actin

migrates considerably slower on SDS-PAGE (45-47,000 M.W. range) than
the 40,000

r~.w.

protein.

Cross-reactivity of our antiserum with actin may be due to
contamination of the original p25 preparation used for inj ect ion in
rabbits.

However, the antiserum may be detecting cross-reactivity

between the Thy 1 and actin.

Dales et ale (31) discovered IOC>noclonal

antibodies with affintiy for Thy 1.1 and Thy 1.2 which also bind to
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actin and vimentin.

Computer analysis of amino acid sequences of

murine Thy 1.2, rabbit and chicken skeletal or smooth muscle actin and
rabbit vimentin showed suggestive sequence homology.

However, exposure

of living Thy 1.2 or 1.1 thymocytes to actin antibody did not produce
any detectable surface binding which demonstrates the absence of actin
from the thymocyte surface.
In conclusion, the hUMan thymocyte Thy 1 must be rrore similar to
the 40,000 M.W. dimer than the 25,000 M.W. antigen isolated from
Molt-3, a human T lymphoblastoid cell line.
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Table 1
Amino acid
tryptophan
Tonamura's
amino acid
4 .7 xl04 to

compositions are expressed in rnol%;
and cysteine are not included. Data from
laboratory was converted from number of
residues for a rrolecular weight of
lID

110.

Amino
acid

Actin

Asp
Glu

9.5
7.5
6.8
13.7

Pro

2.2

G1y

10.5
8.6
4.6
4.7
6.6
9.0
3.0
1.0
2.6
5.0
4.6

Thr

Ser

Ala
Val

Met
lie

Leu
Tyr
Phe
His

Lys
Arg

Actin*

9.3
7.2
6.4
10.6
5.0
7.4
8.1
5.2
4.2
7.5
7.0
4.2
3.2
2.0
5.6
5.0

*Data from Tonomura et ale (22).
**Corrected values.

Thy 1

Thymus**
antigen

12.0
6.3
6.2
13.4
5.9
3.1
5.7
8.0
1.4
4.2
9.6
2.6
3.6
1.8
7.9
4.8

10.9
5.1
6.9
10.4
5.5
5.0
8.7
6.2
0.7
3.6
8.5
6.6
5.1
3.5
5.4
4.7

Human
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Fig. 1.

Flow sheet for isolation of human Thy 1 from Molt-3 cells.

The same procedures . were used in human thymocyte isO'lation.

Thymocytes OR Molt 3 Cells

I
Disr~Pted
---------400

15 min

--~------~Sl

4xl0 3g 20minl

fJ3

S;
I

~

thanol

0

0 overnight

2x104g 15min

PA

!4

Resusgend in 2.5% DOC
Sti r 3 C overnight
1x 106 9 1hr

S (a)
l5

5
Column:
Washed with:
Eluted with:

OR

Lenti I lectin
IOmM Tris-HCI.5%DOC
0.3% mannoside

(c)
Unbound & Bound OR

I

Bound
I
Sephacr>,f 200
LMW fraction

f5(bl
immunoadsorbant
PBS
IM Acetic Acid

I

Air Dialysis

I

Preparative SDS-PAGE

I
Miniature G-25 Desalting Column
(a) Standard isolat ion procedure.
(b) Isolation using anti-p25 column.
.
(c) Fract ionation of bound & un bound material by preparative gels.
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Fig. 2.

A densitometric tracing of the LMW fractions collected from

8-200 superfine column of a Molt-3 preparation and a human thymus
preparation Which were applied to a 12.5% SDS-PAGE and stained with
silver nitrate.

Thymus

p25

Q)

<-'
ow-

Molt 3

o

LMW Fraction from S~200 Column

Fig. 3.

An ELISA assay showing reactivity of rabbit anti-p25 with

materials bound to lentil lectin and those unbound to lentil lectin
fractions isolated by preparative SDS-PAGE from thymocytes.

The x-axis

denotes dilution of antisera and the y-axis is absorbance at

414 nm.

Thymus Bound#4

.500

~
_______u_n_b_o_u_n~d_#_5________________~__~__ *
40

80

160

*Includes Bound fractions 1,2,3,5,6 and Unbound fractions 1,2,3,4,6,7
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Fig. 4.

An Elisa assay showing reactivity of anti-p25 sera with human

Thy 1 isolated form Molt-3 and bovine muscle actin.

1.000
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Dilution of ant i - p25 serum

500

I

/
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Fig . 5 .

A gel densitometric tracing of a 10% SDS-PAGE stained by the

silver nitrate method .

The top of the gel proceeds from the left to

the' dye front on the right .

Relative positions of actin and

immunoglobulin light chain are shown .

Actin

L -chain

J

J.

I

(

~

o
Q.

.....o

Lentil Lectin Bound Fraction # 4
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Fig. 6.

Gel densitometric tracings of two 12.5% SDS-PAGE stained qy

the silver nitrate method.

The sample is taken from the 1 M acetic

acid wash of the anti-p25 immunoadsorbent column immediately after
elution.
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o
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Fig. 7.

Same as Figure 6 except the samples were taken from air

dialysis concentrated 1 M acetic acid wash of the anti-p25 column.
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Fig. H.

Same as Figure 7 except the samples were further concentrated

and were run simultaneously on the same 12.510 SDS-PAGE.
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THE THY 1 K)LECULE APPEARS TO BE A LIPCX;LYCOPROTEIN
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INl'RODUCTION
Two other forms of the human Thy 1 (p25) molecule have been noted
and biochemically characterized (1).

One form is approximately 40,000

MW (p40) according to SDS-PAGE, the dimerized form of p25 and the other
is 16,000 M\-;r (p16), possibly a breakdown product of the p25.

Both

forms are reactive with antisera made to the human Thy 1 or p25
antigen.

The p40 and p25 seem to have almost identical amino acid

compositions.
similar.
similar

The amino acid composition of the p16 is also very

The carbohydrate composition of the p40 and p25 are very
~ile

the p16 seems to have little carbohydrate.

The most

unusual characteristic of these molecules is the possession of lipid
components, two fatty acids, again in almost identical proportions in
the p4 0 and p25 t yet di fferent although present in the p16.
seem to suggest that the human Thy 1 is a lipoglycoprotein.

These data
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MATERIALS AND METHODS

The p25, p40 and p16 molecules were isolated and vurif1ed as
described previously using preparative SDS-PAGE and a miniature
desalting G-25 column (1).
Fatty acid analysis:

The n-hexane extracted material from the

hydrolyzed sample from alditol acetate preparations (2) or from Trimethyl silylated (T~3) preparations (3) were evaporated under nitrogen.
Approximately 25 ul of Tri-Sil (Pierce) was arlded to the alditol
acetate samples.

Normal fatty acids were determined qualitatively and

quantitatively by gas-liquid
esters obt ained frOT'l the

chromatograp~

of the fatty acid

met~l

~thanolyza te.

The sample was reconstituted in chloroform and injected onto a
SP-2330, 6 ft x 2 rom

glass gas chromatography column.

1~

Initial

temperature v.as 160·c, held for 10 min and increased to 190°C at a rate
of 3· /min and held at the final temperature for 20 min.
temperature

was 250°C.

Inj ection

The carrier gas was nitrogen at a flow rate of

20 ml/min. Using a flame-ionization gas chromatograph, 1 ug of each
fatty acid could be arlequately detected at 32 x 10 -1- AFS sensitivity.
The area of the c16 peak was di vided by the area of the CI8 peak to
determine ratios for each molecule tested.
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RESULTS

Whether the samples were desalted or not desalted, the same
results were obtained on the fatty acid analysis.
ratio of the first peak to the second peak.

Table 1 gives the

The tvo fatty acids seen

to be be c16 0 and CI8 I according to the elution times of the fatty
acid standard (Pierce).

For three different extractions the ratio for

the p25 and p40 were very similar (.68).
always less (.51).

The ratio for the p16 was

Other bands that were eluted fran the gel, such as a

12,000 MW,a 20,000 MW and a 67,000 ~w bands did not have aQY fatty
acids according to this

ass~.

These two peaks were not present when

the aggregated p25 and p40 were analyzed.
peaks we re seen.

In one

ass~

more than

t~o
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DISCUSSION
There is an unusual carboxyl terminal found on the Thy 1 molecule.
When sequencing rat brain Tny 1, Campbell (4) could obtain the
C-ter.minal peptide either in h1ghlyaggregated form or could purifY it
only in Brig 96 detergent.

It appeared to have hydrophobic properties

yet contained fev nydrophobic amino acids.

He found unidentified

ninhydrin-positive material and glucosamine and galactosamine.
suggested that the C-terminal may be linked to lipid.
~uld

make the Thy 1 and unusual molecule indeed.

He

If so, this

Barclay and

coworkers (5) mentioned minor unidentified peaks in carbohydrate
analysis which they thought to be stearic acid.

Other investigators

such a.s Sauser (6) assumed a IlX)lecular canplex between a protein roiety
'. and a glyco1.tpid existed for the Thy 1.
covalently or

~drogen

If lipid is present, is it

bonded to the molecule?

We performed a fatty acid analysis on the n-hexane extraction of
hydrolyzed

~

fatty acids.

0, p25, or p16.

Surprisingly,. we found two fairly common

The ratio of the c16 to the c18 fatty acid

~s

almost

always identical in the p40 and p25 molecules, however the p16 ratio
vas always less.

Again this demonstrates that tbe p40 and p25 are t he

same molecule and the p1 6 is differing in the a spect of lipid content
in addition to possessing less carbohydrate (1).

We as s ume t hat these

two fatty acids are part of a lipid moiety bound to the molecule.

The

lipid moiety must be covalently bound since the antigens were extracted
from a Tris-glycine SDS-polyacrylamide gel.
components would migrate to the dye front.

Nonnally free lipid
This would also explain our

loss of the p25 antigen when dialyzed against buffer containing no
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detergent. ' Sauser (6) also found that prolonged dialysis against cold
distilled vater or repeated freezing and thawing of the protein reduced
antigenic activity. ' Lipid has a high affinit,y for dialysis membrane.
There are very few examples in the literature of lipid covalently
attached to protein.

One example is that of Rantke and Braun (7) who

characterized a murine-lipoprotein, in which a thioether bond linked a
cysteine side chain to a diglyceride and a third fatty acid is attached
to the N-terminal amino acid group of the cysteine.

Fatty acids can

also be covalently attached to carbohydrate such as the sugar glucose
in the case of acyl-glucosylcerarnides (8).

We tend to favor the

proposal that lipid is attached to the p25 molecule via a carboxyl
terminal cysteine similar or identical to cysteine #111 or #112
identified from sequence data of mouse and rat Tqy 1

(~,9)

•.
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Table 1.

FATTY ACID ANALYSIS

ratio of C16 peak

p25

p40
p16

'" composition of p25

= .68
= .68
= .51

(3)

(3)
(3)

2.7~

C16

3.1%

C18

6.8%

total

0
1

The number in parenthesis is the total number of
extractions tested.
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Figure 1.

A gas chromatograph tracing of a fatty acid analysis of the

p25 molecule showing the presence of two peaks corresponding to C16 and
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The. Thy 1 or theta antigen was one of the first differentiation
antigens on lytnphocytes to be dese rlbed.

However useful it has been in

the mouse model, to date ' such does not hold true for the rat, dog, or
human since the antigen does not show

similari~

across species except for expression in brain.
few human

~phocyte

in tissue distribution
When this study began

antigens had been biochemically characterized

beyond molecular weight detennination .

This was due to two reasons:

one, the unavailability of human tissue and, two, the relatively low
density of memb rane antigens on cell surface nB.king necessary large
amounts of material or tissue in order to isolate purified antigens in
sufficient

a~ount

for biochemical studies.

In our case, this problem

was overcome by utilizing large-scale cell cultures of a human T
lymphoblastoid cell line, Molt-3 (1) .

The same isolation procedure

using DOC as solubilizing detergent as used for lIX)st murine Thy 1
isolation was used for human material.

A T cell antigen of molecular

-we ight 25,000 was isolated from the Molt 3 cell line (2).
The p25 antigen when canpared to the murine Thy 1 had the same
molecular weight, bound to lentil lectin (a characteristic of
glycoproteins 'Which p::>s sess mannose), and by using immunodepletion and
immunoabsorption experiments it was revealed murine Thy 1.2 and p25
were cross-rea ctive.

This immunological data was borne out by

biochemical data showing similarity but not identity utilizing amino
acid composition, tryptic peptide maps and carbohydrate analysis.

In

addition, our data demonstrated antigenic de t erminants shared by mur i ne
IgG and hll.lnan Thy 1 as well as human thymocyte.

We also demons trate a

diineric form and a non-carbohydrate bearing form of the molecul e.

It

is our contention that the p25 antigen is the mouse

T~

1 or theta

equi valent.

Antiserum made to the isolated and purified T cell product, the
p25 molecule, reacted strbngly with a purified B cell product, human
IgG.

Cross-reactivity with human IgM, 19A, primate Ig, murine Ig, and

a battery of other antigens is low or non-existent.

Both the Fab and

Fc portion of the human IgG molecule reacted vith the antiserum,
wherease reduced and alkylated, or trypsin-digested IgG did not.

This

suggests a defined, tertiary structure of the molecule which includes
the disulfide bonds as necessary 'for reactivity.

Carbohydrate noieties

on the IgG molecule were definitely ruled out while the disulfide bonds
of the first and third domains of human IgG are implicated as the
reactive site.

Perhaps ., isolation and purification of the p25 molecule

us ing DOC exposed new antigenic sites not exposed on the cell surface,
thus the cross-reactivity to IgG.

Molt 3 does not possess nor

synthesize IgG.

These observations are interesting in light of theory recently
proposed by Williams and Gagnon (3) suggesting that the Thy 1 molecule
may be or is like the primordial immunoglobulin domain or the theory

proposed by Jensensius and Williams (4) that the Thy 1 molecule is the
T cell receptor.

Our da ta see"ns to support the previous proposal of

homology between Thy 1 and Ig, howeve r, the 1a tter pr oposal rena ins as
speculation.

Recently, utilizing monoclonal antibodies there have been examples
of shared antigenici ty of Thy 1 and act in (5) and '!'hy 1 and a canponent

146

of 1ntennidate filaments (6).

These investigators also suggest

homology based on a computer search and

campa~i8on

of sequence data.

Extrapolating from shared antigenic determinants to molecular homology,
and especially extrapolating further into shared similar function is a
tenuous area of speculation.
During isolation of the p25 antigen, two other forms of the
antigen were noted and characterized.
designated the p40 molecule.

One being the dimerized p25, is

At first appearance, this band on SDS-

PAGE was confusing until it was noted that preparative SDS-PAGE greatly
increased its presence.

Immunoblot experiments of DOC membrane extrac-

tions and SDS membrane extraction showed that SDS converts the p25 form
into the p40 form.

This supp::>rts Sauser et ale (7) whose data in 1974

demonstrated that the muse Thy 1 is a: 40,000 dalton IlDlecule.

Sauser

is the only investigator in the literature who used 2% SDS instead of

2.5% DOC to isolate the molecule.
used.)

(Brig 96 and Nonidet have also been

Other investigators (8) have assuned that a contaminating

molecule of 40,000 daltons was present in Sauser's thymocyte preparat ion and assume a "true" !ll)lecular weight of the Thy 1 molecule to be
25,000.

Our data are the first to support and vindicate Sauser's work.

The otber fom isolated was the p16 molecule which is p::>ssibly a
breakdown product of the p25.

Ades and coworkers (14) found a 16,000

MW molecule associated with suppressor cells.

The

~101t

3 cell line

possesses both the p25 and the p16, Whereas the Molt 4 possesses the
p25, yet lacks the p16 antigen.

Although biochemical studies bore out
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the identity of the ~
p16 .

° and p25 molecule

t

the same

\laS

not true for the

Amino acid · compositions were very similar which suggests the

protein structure or backbone 'W.s intact.

However t the p16 appeared to

possess considerably less carbohydrate than the p25 molecule, yet
retained lipid material according to fatty acid analysis.
molecule has not been reported in the murine system).

(Such a

The pl6 could be

a cryptic antigen, i.e., part of the p25 structure removed by enzymatic
degradation.

Perhaps the pI6 could be the p25 processed in the cyto-

plasm without the attachment of carbohydrate and then inserted in the
membrane.

The pI6 molecule may play a role in suppressor T cell

function or be a differentiation antigen co-expressed on these cells.

Determination of molecular weight is dependent on the method of
iso lation used and t h is statement is especially true when dealing vi th
surface membrane antigens.

Membrane roolelcules are usually present in

relatively small amounts and detergent is necessary for their isolation.

Deterge nt can be difficult to work with and can interfere vi t h

biochemical methods such as amino acid sequencing.

The histocompati-

bility leukocyte antigens (liLA), though membrane antigens, were
sequenced fairly . easily because it was determined that a papain single
enzymatic cleavage site close to the cell surface would separate t he
majority of the molecule from its qydrophobic tail piece (9,10).
The standard isolation procedure used for isolation of Thy 1
utilizes DOC and yields a product of 25,000 MW by SDS-PAGE.
by sedimentation studi es the M"w is. 17 -18 9 000 (11).

However,

We have shown t hat.

by using SDS in place of DOC the rrolecule' s apparent molecular "'Weight

14S

is 40~000.
antigen.

Atwell and Marchalonis (12) isolated a 60,000 MW theta
This could be due to further aggregation of the molecule

since they used an immunoabsorbant column in their isolation proceudre
and eluted the IIB.terial wi th 1M acetic acid.

'!'his is in contrast to

Cotmore (13J who also used an imrnunoabsorbant column, but eluted vi th
diethylamine and retrieved a molecule of 25,000 MW.

In our studies,

when the p25 and p40 were fixed in a TCA-Coomassie blue solution,
both aggregated to approximately 110,000 MW.

th~

Kuchel (11) found mouse

Thy 1 aggregates in the absence of detergent to a IJX)lecul ar weight of

230,000-300,000.

Therefore, cons ideration of isolation procedures is

important in reporting IIDlecular weight.
The p40 or dimerized form of the p25 antigen is a curious molecule
because it does not revert h8.ck to the p25 form when treated with a
reducing agent.

This suggests that dimerization is not due to

disulphide bond interchange.

Perhaps another form of interchange has

occurred and we specul ate that the :qydropbobic portion of the IIDlecule
plays a role i n this.

If lipid or fatty acids are present, any

unsaturated bonds may interchange between fatty acids.

H
HHHH
2 H-C(n)-C-C=C-C(n)-R
H
H
H

=

H
HHH
H
R-C(n)-C-C-C(n)-C-H
H
H H
H
H H

H H

H-C-C(n)-C-C-C(n)-R
H H

H H H

Of course at his time, this speculation remains to be proved.
It was of .i mportance to determine 'Whether the p25 molecule coul d
als o be found on nonnal tissue and whether identity existed wi th the

149

p25 material isolated froo the lymphoblastoid cell line.

After using

similar' amounts of huma..n thyzoocyte as used in a Molt 3 isolation,
Ii tt1e if any 25 ,000 HW band was seen on SDS-PAGE of the LMW peak from
gel filtration.

Yet · When preparative gels were run on tnymocyte

material which was concentrated from the bound and unbound eluate of a
lentil lectin column, a fraction corresponding to bound, 40,000 MW,
reacted with anti-p25 serum.

None was noted in the 25,000 MW range.

When a DOC membrane preparation of human thymus was applied to an
anti-p25 imnrunosorbant c o lumn, washed and eluted with 1 M Acetic Acid,

tva peaks were observed on SDS-PAGE.

When concentrated by air dialysis

only a single band was observed on gels.

Some conversion had occurred

in the Holt 3 preparation but not to the extent of complete conversion
as seen with the thymus material.

The thymus material and p25 antigen

had very simi l ar ami no acid compositions.

The antigen may exist in the 25,000 MW form on the human
yet because it is

p~e s ent

t~mocyte

in quantities considerably less than that

found on f.101t 3 «10'% ) , perbaps it is IIDre readily converted into a
dimerized form.

Ritter (15) also found Thy 1 to be present in small

amounts in the human tqy-mus (0.2-10%).

Therefore, the Thy 1 antigen

cannot be used as a T cell di ffer'entiation marker in the human, as is
also true in the dog.

The mouse appears to be the only animal in which

the Thy 1 antigen appears in abundance on peripheral T lymphocytes.

Only in rodents does the Thy 1 appear in abundance on thymus, in
c ont.rast to the dog a nd human.
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Our studies suggest the presence of lipid in the p25 molecule.
This is shown ~ 1) the necessity of detergent for its isolation,
2) the removal of detergent by dialysis results in loss of the p25
molecule and 3) n-hexane extractable material 1n ~drolyzates of the
p25 molecule.

The material which lends hydrophobicity to the molecule

is probably covalently attached.
In summary, evidence which supports the homology of murine Thy 1
and the human Thy 1 or p25 antigen is:
1.

both are 25,000 MW by SDS-PAGE.

2.

both are glycoproteins ~ ich contain high rrnnnose content,
i. e. ,they bind to Lens culinaris lentil lectin.

3.

Cross-reactivity has been shovn by
immunodepletion experiments.

4.

Amino acid compositions are similar, yet not identical.

5.

Tryptic peptide maps are similar, yet not identical.

6.

A 40,000 MW form can be seen with SDS-conversion.

7.

~oabsorption

and

HPLC tryptic peptide maps of the p25 contain 12-14 peptides as
_vould be expected for the number of arginines and lysines in
the amino acid compositions.

8.

The p25 molecule possesses approximately 2Cf/o carbohydrate
compared to the murine content of 20-30%.

9.

The N-terrninal amino acid of the p25 appears to be blocked as
1s . true of the rodent Thy 1. Serine appears to be the amino
acid following methionine as is true of IIDuse but not rat Thy
1.

Additional observations accomplished include; antigenic
determinants shared by human IgG and human Thy 1 antigen, the presence
of a molecule related to the p25 of 16,000

~fW,

and a human thymus

40,000 MW glycoprotein is related to the human Thy 1.

151

REFERENCES

1.

Zverner,. R.; Barstad, P. and R. Acton.

"Isolation and Characteri-

zation of Murine Cell Surface Components. I. Purification of Milligram Quantities of Thy 1.1".

2.

J. Ex!'. Med. 146; 986-1000, 1971.

Ades, E.W., Zwerner, R.K., Acton, R.T., and C.M. Balch.
tion and Partial Characterization of the

1" •

3.

J. Ex!'. Med. 151;

Williams, A.F. and J. Gagnon.

"Neuronal Cell Thy 1 Glycoprotein:
Science 214; 696-703, 1982.

Jensenius, J.C. and A.F. Williams.
Receptor-Paradigm Lost".

5.

of Thy

400-406, 1980.

Homology with Immunoglobulin".

4.

Hu~n Homolo~le

"I sola-

The T Lymphocyte Antigen

Nature 300; 583-588, 1982.

Dales, S., Fujinami, R.S. and M.B.A. Oldstone.

"Serologic

Relatedness Between Thy 1.2 and Actin Revealed by Monoclonal Antibody".

6.

J •. Immunol. 131; 1332-1338, 1983.

Du1becco, R.M., Unger , M., Bologna, H., Battifora, H., Syka, P.
and S. Okada. .

"Cros s-react ivi ty Between Thy 1 and Component of

Intermediate Filaments Demonstrated Using a. f-1onoclonal Antibody".
Nature 292; 772-774~

7.

1981.

Sauser, D., .A..nckers , C. and C. Bran.

"Isolation of Mouse Thymus-

Derived Lymphocyte Specific Surface Antigens".

617 -624, 1974.

Immunol. 113;

152

8.

Barclay, A.
Faulkes.

Letarte-Muirhead, M., Williams, A.F. and R.A.

t

"Chemice.l Characterization of the Thy 1 Glycoproteins

from the Membranes of Rat Thymocytes and Brain".

Nature 263,

563-567 t 1976.

9.

Shimada, A. a.nd S.G. Nathenson.
(H-2) A11oantigens.

"Murine Histocompatibili ty-2

Purification and Some Chemical Properties of

Soluble Products from H-2b and H-2d Genotypes Released by Papain
Digestion of Membrane Fract ions" •

Biochemistry 8; 4048-4062,

1969.
10.

-T urner, M.J.

~

Cresswell, P., Parham, P., Strorninger, J .L., Mann,

D.L. andA.R. Sanderson.

"Purification of Papain-Solubilized

Histocompatibi1i tyAntigens from a Culture Human Lymphoblastoid
Line RPMI

11.

4265".

Kuchel, P.W.,

J. BioI. Chern.

Campbe11~

250; 4512-4519, 1975.

D.G., Barclay, A.N. and A.F. Williams.

"Molecular Weights of the

~ rv

1 Glycoprot eins from Rat Thymus and

Brain in the Presence and Absence of Deoxycholate".

Biochem. J.

169; 411-417,1978.
12.

Atwell, J

.E., Cone, R.E. and J.J. Marchalonis.

"Isolation of

Theta Antigen fr om the Surfa.ce of TrJj1nUs Lymphocytes".
Lond.

13.

Nature,

263; 563-567, 1976.

Cotmore, S.F., Crowhurst, S.A. and M.D. Waterfield.

"Purification

of Thy 1 Related Glycoproteins from Human Brain and Fibroblasts:
Comparisons Between these Molecules and "'htrine Glycoproteins
Carrying Thy 1.1 and Thy 1.2 Antigens".

597 -603, 1981.

Eur. J. Immuno1. 11;

153

14.

Balch, C.M., Loken, M.R., Dougherty, P.A. and E.W. Ades.
"Expression of

8.

16,000 Molecula.r Weight Antigen on Human

Suppressor T Lymphocytes".

15.

Cellular Immunol. 64, 84-92, 1981.

Ritter, M.A., Sauvage, C.A. a.nd D. Delia.

''Human Thy 1 Antigen;

Cell Surface Expression on Early T and B Lymphocytes".

49; 555 -564, 1983.

Immunol.

154

Appendix

155

Distribution of Cell Surface Tqy 1 Antigen in Human Haemopoietic Cell
Lines as Compared to Balb c Tbymocytes and a Primate Cell Line.
T Lymphoid Lineage

Cell Line

Binding · 100%
Counts
Lysis

Neg.
Control

Dilution (l:X)
%Lysis

x=4
Molt 3*
Molt 4*
Molt 21*
HPB-MLT*

HPB-ALL*
JM*
SB

W.M.
( woolly JlX)nkey
T cel l)
Balb c thymocytes
CEr~

band

CE1"~

pellet

2,000
5,000
7,000
2,0 00
2,000
2,000
2,000
6,000
300

70
71
76
84
72

15
17
20
33

81

21
17

16

32

64

48

41

80

84 84

79

63

15

12

8

23
27

23

57
85

13

89

53

+

+

B Lymphoid Lineage
Raj i

NaIrn 1**

6**
115

Nalm
PC

RN 114

RPMI 8392
BallI

*Early T cell

**Pre B cell

3,000
6,000
600
15,000
3,000
11 ,000
4,000

79
82
73

66

82
46
83

12
18
46
20
12
13
13

78
42

69
27

22

28

12

29

51
45
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